Stockwinners Market Radar for September 06, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:41 EDT San Juan Basin Royalty Trust enters into $1.04M settlement agreement - PNC Bank, National Association, as the trustee of the San Juan Basin Royalty Trust, announced that an agreement between the Trustee and Hilcorp San Juan L.P., the owner of the Trust's subject interests, will result in the payment of $1,037,093.45 to the Trust by Hilcorp to resolve the 2017-2020 Disputed Expenses exceptions and enter into an amendment to the Conveyance Agreement with respect to the expenses associated with the operator's saltwater disposal facilities. The Trustee routinely engages with Hilcorp regarding its ongoing accounting and reporting to the Trust with respect to revenue and expenses for operated wells, inclusive of sales revenues, production costs, capital expenditures, adjustments, actualizations, and recoupments, as well as a detailed analysis of Hilcorp's pricing and rates charged. These revenues and costs (along with all costs) are the subject of the Trust's ongoing comprehensive audit process by our professional consultants and outside counsel to ensure full compliance with all the underlying operative Trust agreements and evaluating all available potential remedies in the event there is evidence of non-compliance.

20:02 EDT Cathie Wood's ARK Investment bought 466K shares of Invitae today

19:59 EDT Aspen Aerogels director buys $308.5K in common stock - In a regulatory filing, Aspen Aerogels disclosed that its director Steven Mitchell bought 50K shares of common stock on September 5th in a total transaction size of $308.5K. Shares of Aspen Aerogels are up 1.6% afterhours at $6.32.

18:45 EDT Axalta Coating director Stein buys 36,600 common shares - In a regulatory filing, Axalta Coating Systems director Kevin Stein disclosed the purchase of 36,600 common shares of the company on September 6 at a price of $27.38 per share.

18:12 EDT Quanta Services exec Wayne sells 5,000 common shares - In a regulatory filing, Quanta Services executive VP and General Counsel Donald Wayne disclosed the sale of 5,000 common shares of the company on September 1 at a price of $210.92 per share.

18:08 EDT Matterport CEO Pittman sells 273,720 class A shares - In a regulatory filing, Matterport CEO Raymond Pittman disclosed the sale of 273,720 class A common shares of the company on September 5 at a price of $2.6139 per share.

17:57 EDT Social network X debuts Community Notes for videos - Social network X, formerly known as Twitter, debuts Community Notes for videos. Community Notes "aims to create a better informed world by empowering people on Twitter to collaboratively add context to potentially misleading Tweets," according to the company. In an earlier tweet, X announced that notes by contributors attached to a video will appear in all posts with that video. "Notes written on videos will automatically show on other posts containing matching videos. A highly-scalable way of adding context to edited clips, AI-generated videos, and more," the company said in a tweet, on X. the social media company owned by elon Musk added "Not just for images anymore - introducing notes on videos! Notes written on videos will automatically show on other posts containing matching videos. A highly-scalable way of adding context to edited clips, AI-generated videos, and more." Reference Link

17:45 EDT Dirtt Environmental Solutions trading resumes

17:35 EDT International Paper announces CEO succession plan - International Paper announced that chairman and CEO Mark Sutton has requested that the board move forward with the next phase of the company's CEO succession plan. This phase in the process will include a comprehensive evaluation of internal and external candidates for Sutton's successor. Sutton will continue in his role as chairman and CEO until his successor is in place. "I am confident that this is the right time to initiate this phase of our multi-year succession plan," said Sutton. "Our experienced leadership team, refined business portfolio, ongoing execution of our transformation strategy and strong balance sheet position the company for our next leader to capitalize on significant opportunities for profitable growth. I look forward to working with our Board of Directors on this phase of the process. I will continue to lead the management team to ensure the company's success and a seamless handoff to my successor."

17:23 EDT KLA Corp. exec sells $7.03M in common stock - In a regulatory filing, KLA Corp disclosed that its Semi Proc. Control President Ahmad Khan sold 14K shares of common stock on September 1st in a total transaction size of $7.03M.

17:14 EDT Fluor to pay $14.5M in SEC settlement - Fluor announced that the company has entered into a settlement agreement with the SEC resolving the previously disclosed SEC investigation of the company. As reflected in the administrative order filed by the SEC, the investigation pertained to the company's accounting on two lump sum engineering, procurement and construction contracts. In connection with the settlement, the company has agreed to pay a civil penalty of $14.5M. The company established reserves sufficient to fund the settlement during 2022 and expects no material earnings effect during 2023. The SEC's investigation concerned two projects that are now largely completed and involved historical transactions that the company restated in September 2020. The SEC settlement follows the previous announcement that the U.S. Department of Justice had ended its investigation into the company.

17:07 EDT National Research Corporation declares special dividend of $1.00 per share - National Research "announced that its Board of Directors has declared a special dividend of one dollar, $1.00, per share to shareholders of record as of the close of business on Monday, September 18, 2023, and payable on Friday, September 22, 2023."

17:02 EDT UiPath jumps 6% to $17.21 after Q2 earnings beat, guidance raise

16:58 EDT Quanex director Griffiths sells 25,000 common shares - In a regulatory filing, Quanex director William Griffiths disclosed the sale of 25,000 common shares of the company on September 1 at a price of $29.0883 per share.

16:55 EDT Dirtt Environmental Solutions trading halted, news pending

16:46 EDT Vacasa announces 1-for-20 reverse stock split - Vacasa "announced that its board of directors has approved a reverse stock split of its Class A Common Stock, Class B Common Stock, and Class G Common Stock at a ratio of 1-for-20. Stockholders approved a proposal to allow the board of directors, in its discretion, to effect a reverse stock split at the Annual Meeting of Stockholders held on May 23, 2023. The reverse stock split is being conducted to regain compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Global Select Market. The reverse stock split is expected to become effective on October 2, 2023."

16:40 EDT Apollo Global's Shutterfly names new CFO - Shutterfly "announced the appointment of Jan Paul Teuwen as Senior Vice President and CFO, effective September 11, 2023. Jan Paul will succeed Mike Eklund, who will be stepping down from the CFO role to pursue other opportunities. Jan Paul Teuwen most recently served as Chief Financial Officer for Lumileds, a global lighting solutions company, where he oversaw the finance, investor relations, global IT operations and other functions. Prior to his time at Lumileds, Jan Paul spent ten years at Philips, the global technology company, where he held controller and FP&A positions with several business areas including R&D, consumer products, retail, and telecommunications, ranging in global revenue of up to $2 billion and complex research and development budgets of $200 million."

16:35 EDT O'Reilly Automotive director sells $1.0M in common stock - In a regulatory filing, O'Reilly Automotive disclosed that its Lawrence O'Reilly sold 1,060 shares of common stock on September 1 in a total transaction size of $1.0M.

16:32 EDT BlackRock TCP Capital, BlackRock Capital Investment enter merger agreement - BlackRock TCP Capital (TCPC) and BlackRock Capital Investment (BKCC) announced that they have entered into a definitive agreement pursuant to which BCIC will merge with and into a wholly owned, indirect subsidiary of TCPC, subject to shareholder approval and customary closing conditions. Following the merger, TCPC will continue to trade on the Nasdaq Global Select Market under the ticker symbol "TCPC" and the surviving entity will continue as a subsidiary of TCPC.

16:30 EDT Fiesta Restaurant announces expiration of 'go-shop' period - Fiesta Restaurant Group announced the expiration of the 30-day "go-shop" period under the terms of the previously announced merger agreement pursuant to which Authentic Restaurant Brands, a portfolio company of Garnett Station Partners, LLC, will acquire Fiesta in an all-cash transaction. The "go-shop" period expired at 12:01 a.m. Eastern Time on September 5, 2023. Pursuant to the merger agreement, Fiesta's Board of Directors, with the assistance of its financial advisors, actively solicited alternative acquisition proposals from potentially interested third parties. None of the third parties contacted by Fiesta or its financial advisors provided an alternative acquisition proposal by the go-shop deadline. As previously announced, ARB has agreed to acquire Fiesta for $8.50 per share. The transaction is expected to be completed in the fourth quarter of 2023 and is subject to approval by Fiesta's stockholders and expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.

16:29 EDT Verint falls 15% to $26.20 after Q2 earnings miss

16:27 EDT Correction: DuPont launches new $2B accelerated share repurchase transaction

16:26 EDT C3.ai down 3% at $30.48 after Q1 results and guidance

16:25 EDT Vaxart monovalent norovirus vaccine candidate study met 5 of 6 primary endpoints - Vaxart announced top-line data from the Phase 2 challenge study of its oral tablet monovalent norovirus vaccine candidate, NCT05212168. The Phase 2 challenge study enrolled 165 healthy adults, who were randomized 1:1 to receive Vaxart's monovalent oral tablet vaccine targeting the norovirus GI.1 genotype or placebo. Four weeks after vaccination, subjects were challenged with GI.1 norovirus. The study achieved its primary endpoints of a statistically significant 29% reduction in the rate of norovirus infection between the vaccinated and placebo arms through Day 8 post challenge, a strong induction of norovirus-specific immunoglobulin A or IgA, and immunoglobulin G or IgG, antibodies, and other immune response endpoints. Vaccination also led to a reduction in norovirus AGE in the vaccine arm compared to placebo, but this was not statistically significant. In a prespecified analysis, the study also showed an 85% decrease in viral shedding in the vaccine arm compared with placebo. "Challenge studies use higher quantities of virus than an individual may encounter during a naturally occurring infection, yet our vaccine candidate demonstrated a significant effect on infection and viral shedding, even though it did not achieve a statistically significant reduction in norovirus AGE," said Dr. James F. Cummings, Vaxart's Chief Medical Officer.

16:24 EDT DuPont completes $3.25B accelerated share repurchase, begins $2.5B new one - DuPont completion the $3.25B accelerated share repurchase transaction launched last November. Additionally, the company has entered into new accelerated share repurchase agreements with multiple counterparties to repurchase an aggregate of $2B of common stock. In connection with completion of the $3.25B ASR transaction, the company received and retired an additional 8.0 million shares of DuPont common stock. In total, the company received and retired 46.8 million shares of DuPont common stock under the $3.25B ASR transaction at an average price of $69.44 per share. In connection with the launch of the $2B ASR transaction, this week the company will pay an aggregate of $2.0B and will receive and retire 21.2 million shares of DuPont common stock, representing 80% of the transaction value based on DuPont's closing share price on September 5th. The company expects to complete the $2B ASR transaction during 1Q 2024.

16:21 EDT MAA announces planned retirement of CFO Albert Campbell - Mid-America Apartment Communities announced that Albert Campbell, executive VP and CFO, will retire effective March 31, 2024. A. Clay Holder, senior VP and Chief Accounting Officer, will assume responsibilities as the CFO effective with Campbell's retirement. As part of his planned retirement, Campbell will remain as an advisor to the company through the end of calendar year 2024 to further support the company and facilitate an orderly transition.

16:20 EDT Dave & Buster's increases share repurchase program to $200M - The company announced that its board of directors approved an increase to its remaining share repurchase program authorizing the company to repurchase up to $200M of its common stock. The program may be suspended or discontinued at any time.

16:19 EDT Equity Residential says Q2 same-store revenue on track with guidance - Equity Residential provided an update regarding certain same store operating trends in its business. Same store revenue growth remains on track with the Company's guidance range described in its second quarter 2023 earnings release. The Company is finishing a good leasing season with healthy demand and pricing for its apartment units. Consistent with normal seasonal demand patterns, in early August 2023 rents peaked for the year and the Company expects rents to moderate for the balance of the year.

16:15 EDT C3.ai launches new C3 Generative AI suite - C3 AI "announced the launch of the C3 Generative AI Suite including 28 new domain-specific generative AI offerings available to address the unique needs of industries, business processes, and enterprise systems. The new offerings combine C3 AI's deep enterprise domain and industry expertise with the latest innovations in generative AI."

16:11 EDT iSpecimen reduces headcount by 20% in organizational restructuring - iSpecimen announced that the board of directors has approved an organizational restructuring plan in an effort to improve performance and drive shareholder value. iSpecimen announced immediate headcount reductions of approximately 20% of the company's total workforce and additional expense reductions after streamlining operations and rationalizing resources to focus on key market opportunities. Recently, the company completed its implementation of lines of business teams and next day quotes to shorten sales cycles, improve quote-to-purchase order ratios, increase fulfillment and accelerate revenue generation. As a result of these changes, monthly expenses related to headcount, including other employee turnover during the year, as well as all other monthly operational costs, are expected to decrease by approximately 29% and 52%, respectively, compared to the average monthly costs for the first eight months of the year. iSpecimen recently announced the launch of its virtual cancer sequencing procurement program aimed at providing researchers with consistent and direct access to cancer tumor tissues. The genetic signatures of cancer tumor tissues provide important information necessary to develop new treatments and diagnostics. Through this new offering, cancer researchers can advance their work by efficiently accessing these highly sought tumor tissues from iSpecimen, overcoming the existing manual, time-consuming and costly process of requesting biospecimen samples from multiple sources and suppliers.

16:07 EDT ZIM Integrated announces new operational collaboration with MSC - ZIM Integrated Shipping Services Ltd. announced a new operational cooperation agreement with MSC, the industry's largest carrier, encompassing several trades. This agreement is designed to "significantly enhance operational efficiencies and further elevate service levels" for ZIM's customers. The cooperation scope includes services connecting the Indian subcontinent with the East Mediterranean, the East Mediterranean with Northern Europe, and services connecting East Asia with Oceania. The agreements between ZIM and MSC includes vessel sharing, slot purchases, and swap arrangements.

16:05 EDT Boston Scientific's Watchman FLX device approved by FDA - Boston Scientific has received FDA approval for the latest-generation Watchman FLX Pro Left Atrial Appendage Closure Device. Designed to further advance the procedural performance and safety of the WATCHMAN technology, which is indicated to reduce stroke risk in patients with non-valvular atrial fibrillation who need an alternative to oral anticoagulation therapy, the device now features a polymer coating, visualization markers and a broader size matrix to treat a wider range of patients. Data across several preclinical studies demonstrated that the polymer coating provided an 86% reduction in inflammation three days following the procedure, a 70% reduction of thrombus at 14 days and a 50% increase in endothelial tissue coverage 45 days post procedure.

16:04 EDT Crescent Energy to acquire additional interests in Western Eagle Ford position - Crescent Energy Company announced that it has entered into a definitive purchase agreement to acquire incremental working interest in its operated Western Eagle Ford assets for total consideration of $250M in cash, subject to customary purchase price adjustments. The acquisition follows the recent $600M acquisition of operatorship of the Western Eagle Ford position that closed in July 2023. Crescent CEO David Rockecharlie said, "We are pleased to further scale our high-quality Western Eagle Ford position following the recent acquisition of operatorship of this asset earlier in the quarter. This transaction is consistent with our strategy to grow opportunistically through accretive acquisitions, adding low decline cash flow and high quality inventory at attractive valuations while maintaining financial strength. With increased scale and operational control, we believe there are significant opportunities to realize meaningful synergies across our broader Eagle Ford footprint." The assets are within Crescent's existing operated footprint and are primarily located in Dimmit and Webb Counties, Texas. The transaction is expected to close in September 2023, subject to customary closing conditions, with an effective date of June 1, 2023. In conjunction with the signing of the transaction, the Company entered into additional hedges in-line with its risk-management strategy.

16:01 EDT Amneal Pharmaceuticals gets FDA approval for calcium gluconate injection - The company states: "Amneal Pharmaceuticals announced it has received Abbreviated New Drug Application approval from the FDA for calcium gluconate in sodium chloride injection, 1000 mg/50 mL and 2000 mg/100 mL. This injectable product is currently on the U.S. FDA shortage product list. The product approval received the FDA's Competitive Generic Therapy designation with 180-day exclusivity. Amneal has the highest number of CGT approvals in the U.S. Generics industry. According to IQVIA(R), U.S. annual sales for calcium gluconate in sodium chloride injection for the 12 months ended June 2023 were $107 million."

15:54 EDT Fitch upgrades GM and GM Financial's IDRs to 'BBB' - Fitch Ratings has upgraded the Long-Term Issuer Default Rating, or IDRs, of General Motors Company, General Motors Financial Company, and GMF's General Motors Financial of Canada, Ltd. subsidiary to "BBB" from "BBB-". Fitch stated: "The upgrades of GM's ratings reflect Fitch's view that the supply chain challenges and resulting production volatility of the past two years have largely abated. The ratings also reflect Fitch's expectation that the company's EBIT margins, FCF margins and leverage will all remain stronger over the intermediate term than those outlined in Fitch's previous positive rating sensitivities. GM continues to maintain a strong liquidity position and a balanced capital allocation policy that prioritizes financial flexibility and low leverage. The current labor negotiations create some near-term uncertainty, but Fitch expects the company to ultimately reach agreements that will remain supportive of its 'BBB' IDR."

14:37 EDT Beyond Meat down 6% in afternoon trading - Archer Daniels (ADM) stated while presenting at the Barclays conference that "on the plant based side of things, we continue to see destocking along with a slower rate of demand for plant based. And that's not all plant based. It's primarily plant based meat category," according to a transcript of the event. Shares of Beyond Meat (BYND) are down 6% to $11.08 in afternoon trading amid the commentary.

13:56 EDT North American rail traffic down 5.2% for the week ending September 2 - The Association of American Railroads, AAR, reported U.S. rail traffic for the week ending September 2, as well as volumes for August. U.S. railroads originated 1,133,375 carloads in August 2023, down 2%, or 23,323 carloads, from August 2022. U.S. railroads also originated 1,239,290 containers and trailers in August 2023, down 6.3% or 83,717 units, from the same month last year. Combined U.S. carload and intermodal originations in August 2023 were 2,372,665, down 4.3% or 107,040 carloads and intermodal units from August 2022. "August was the third straight month in which total year-over-year U.S. rail carloads have fallen," said AAR Senior Vice President John T. Gray. "A major reason why is that other than automotive manufacturing, the industrial economy, in recent months, has not been doing as well as other areas of the economy. Until industrial activity, and especially manufacturing, recovers, rail volumes in many key markets could remain constrained."...Total U.S. weekly rail traffic was 476,851 carloads and intermodal units, down 5.4% compared with the same week last year. Total carloads for the week ending September 2 were 231,113 carloads, down 1.6% compared with the same week in 2022, while U.S. weekly intermodal volume was 245,738 containers and trailers, down 8.7% compared to 2022. North American rail volume for the week ending September 2, on 10 reporting U.S., Canadian and Mexican railroads totaled 337,338 carloads, down 0.1% compared with the same week last year, and 328,232 intermodal units, down 9.9% compared with last year. Total combined weekly rail traffic in North America was 665,570 carloads and intermodal units, down 5.2%. North American rail volume for the first 35 weeks of 2023 was 22,675,055 carloads and intermodal units, down 4.1% compared with 2022. Publicly traded companies in the space include CSX (CSX), Canadian National (CNI), Canadian Pacific Kansas City (CP), Kansas City Southern (KSU), Norfolk Southern (NSC), Union Pacific (UNP),Trinity Industries (TRN), Greenbrier (GBX), Wabtec (WAB), FreightCar America (RAIL) and Rail Vision (RVSN). Reference Link

13:52 EDT Alteryx trading resumes

13:47 EDT Alteryx trading halted, volatility trading pause

13:42 EDT DocGo receives HPD letter regarding agreement with Rapid Reliable Testing NY - According to a regulatory filing, on September 5, 2023, the Comptroller of the City of New York issued a letter to the Commissioner of the Department of Housing Preservation and Development regarding HPD's agreement with Rapid Reliable Testing NY LLC, a subsidiary of DocGo Inc.,, for the provision of certain services to asylum seekers. In the Comptroller Letter, the Comptroller indicated that his office was returning the Agreement to HPD without approval. On September 6, 2023, the Company received a letter from HPD stating that, notwithstanding the Comptroller Letter, (i) HPD intends to inform the Comptroller that he is required to take the necessary steps for HPD to make payments under the Agreement, (ii) there is no risk of non-payment as a result of the Comptroller Letter, and the Company will be paid in accordance with the Agreement, and (iii) payment under the Agreement will commence promptly. A copy of the HPD Letter is attached to this Current Report on Form 8-K as Exhibit 99.1.

13:34 EDT T-Mobile authorizes shareholder return program of up to $19B - T-Mobile US (TMUS) announced that its Board of Directors has authorized a shareholder return program of up to $19.0B that will run through December 31, 2024. The shareholder return program is expected to consist of additional repurchases of shares of the company's common stock and payment of cash dividends. The company intends to declare and pay its first dividend of approximately $750M in the fourth quarter of 2023 and then to pay approximately $3.0B in total additional dividends in 2024, with payments occurring each quarter during the year. The dividend amount paid per share is expected to grow by around 10% annually. The amount available under the shareholder return program for share repurchases will be reduced by the amount of any cash dividends declared and paid by the company. Deutsche Telekom AG (DTEGY) does not currently anticipate selling shares directly to the company under the shareholder return program, but DT has reserved the right to sell shares of the company's common stock through one or more customary 10b5-1 plans any time after January 1, 2024. "Share repurchases and any dividends declared by the board and paid from time to time are expected to be made from available cash on hand and proceeds of one or more debt issuances or other borrowings, based on the company's evaluation of market conditions and other factors. For the avoidance of doubt, the shareholder return program is in addition to the company's previously announced $14.0B share repurchase program that the board authorized in September 2022," the company stated in a regulatory filing.

13:31 EDT IBM announces data incident for Janssen CarePath database

13:23 EDT Ryvyl announces 1-for-10 reverse stock split - Ryvyl announced that its board approved a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10. The reverse stock split is expected to become legally effective on September 6. The shares are expected to begin trading on the split-adjusted basis on the Nasdaq under the company's existing trading symbol "RVYL" at market open on September 7.

13:13 EDT Vahanna Tech Edge Acquisition I Corp trading halted, volatility trading pause

12:30 EDT Hitek Global Inc trading resumes

12:12 EDT Avid Technology announces commercial availability of Avid Stream IO - Avid is announcing the commercial availability of Avid Stream IO, a new flexible subscription-based software platform for production ingest and playout of news, sports, live entertainment and other TV content. Already, broadcasters around the world - including CNBC-TV18 and BQ Prime- are signing up to take advantage of the new solution at launch. With a flexible architecture that can be configured to ingest or play out IP streams and SDI streams, Avid Stream IO allows news, sports and live content producers to migrate from legacy workflows and on-premises deployment to cloud and IP workflows at their own pace.

12:00 EDT Xponential Fitness falls -10.6% - Xponential Fitness is down -10.6%, or -$2.38 to $20.15.

12:00 EDT AMC Entertainment falls -26.0% - AMC Entertainment is down -26.0%, or -$3.54 to $10.10.

12:00 EDT Sea Limited rises 6.6% - Sea Limited is up 6.6%, or $2.47 to $39.78.

11:49 EDT AT&T: No public health crisis at site mentioned in WSJ lead cable story - AT&T CEO John Stankey, at the Goldman Sachs Communacopia conference, says the company got results back from the EPA on Tuesday after a review of a site mentioned in the Wall Street Journal lead cable story and that the EPA concluded that there is no public health crisis for risk at that site.

11:01 EDT Comcast CEO Roberts says signed modification to Hulu deal with Disney - The agreement brings forward the date to start the process with Hulu, says Comcast CEO Brian Roberts at the Goldman Sachs Communacopia conference. September 30 will be new deadline for the Hulu decision, Roberts says, adding that the $27.5B figure was hypothetical, today's Hulu value is higher. The new Hulu contract has a high appraisal value, says Roberts. The proceeds of any deal will go to shareholders, the CEO says.

10:48 EDT WeWork up 13% after announcing plans to renegotiate or exit leases - WeWork shares are up 45c, or 13%, to $3.99 following the letter from the company's CEO regarding the plans.

10:45 EDT WeWork to renogiate 'nearly all' leases, exit unfit locations

10:11 EDT Vuzix signs distribution agreement with PDC - Vuzix Corporation has entered into a distribution agreement with The Printer Distribution Company, an Africa-based value-added technology distributor of leading solutions in front office, back office and networking applications. Vuzix has received and shipped against an initial volume purchase order from PDC, who will distribute and support Vuzix smart glasses products to its customers across Africa.

10:05 EDT American Battery receives contract for $57M grant from U.S. DOE - American Battery Technology Company has received its $57M contract award from the U.S. Department of Energy for a multi-year project to design, construct, and operate its first-of-kind commercial-scale lithium hydroxide manufacturing facility in Tonopah, Nevada.

10:03 EDT Zimmer Biomet 'very confident' in guidance for 2H23

10:03 EDT Growth for Good Acquisition Corp trading halted, volatility trading pause

10:00 EDT Enbridge falls -6.2% - Enbridge is down -6.2%, or -$2.18 to $33.11.

10:00 EDT AMC Entertainment falls -19.2% - AMC Entertainment is down -19.2%, or -$2.62 to $11.03.

10:00 EDT Soho House rises 6.6% - Soho House is up 6.6%, or 48c to $7.77.

09:53 EDT JetBlue says experiencing system outage, expects fix 'soon' - JetBlue tweeted: "We are experiencing a system outage now. We apologize for the inconvenience. We expect to have it fixed soon." Reference Link

09:47 EDT Asana falls -7.9% - Asana is down -7.9%, or -$1.70 to $19.94.

09:47 EDT SOS Limited rises 5.2% - SOS Limited is up 5.2%, or 20c to $4.07.

09:47 EDT Xponential Fitness rises 5.3% - Xponential Fitness is up 5.3%, or $1.20 to $23.73.

09:39 EDT ADiTx Therapeutics trading halted, volatility trading pause

09:34 EDT Modine Manufacturing announces sale of three automotive businesses in Germany - Modine announced today that it has signed a definitive agreement to sell three Modine businesses based in Germany to affiliates of Regent LP. The businesses are located in Neuenkirchen, Pliezhausen and Wackersdorf. The sale is expected to be completed in the next few weeks pending regulatory approval. "The sale of these businesses is in line with our strategy to focus our resources on high-margin technologies with strong growth drivers," said Neil Brinker, President and Chief Executive Officer of Modine. "These businesses produce and service non-strategic parts for internal combustion diesel and gasoline engines in the European automotive market. Coming on the heels of Modine's acquisition of Napps Technology, the divestiture of these businesses represents our continued commitment to focus on innovative, engineered solutions that help us achieve our long-term margin targets and furthers our purpose of engineering a cleaner, healthier world."

09:29 EDT Diana Shipping announces direct continuation of time charter contract - Diana Shipping has extended the time charter contract with Reachy Shipping for one of its Ice Class Panamax dry bulk vessels, the m/v Crystalia. The gross charter rate is US$11,250 per day, minus a 5% commission paid to third parties, for a period until minimum February 20, 2024 up to maximum April 20, 2024. The new charter period is expected to commence today. The "Crystalia" is an 77,525 dwt Ice Class Panamax dry bulk vessel built in 2014. The employment of "Crystalia" is anticipated to generate approximately $1.85 million of gross revenue for the minimum scheduled period of the time charter.

09:26 EDT Amazon announces lawsuits against 'bad actors' selling counterfeit goods - Amazon and its Counterfeit Crimes Unit or CCU announced the filing of two new lawsuits against Kamryn Russell, Ashley Hawat, and their co-conspirators who knowingly attempted to evade Amazon's brand protection systems in an effort to promote, advertise, and facilitate the sale of counterfeit luxury fashion goods such as jewelry, handbags, and accessories. Amazon works across the globe to fight counterfeiters, filing joint lawsuits with brands to eliminate the sale of counterfeits not only in Amazon's store but across the supply chain. Through its partnership with brands of all sizes, Amazon's CCU constantly uncovers new approaches counterfeiters take to try to deceive customers and evade the law. The CCU uses that intelligence to equip law enforcement to pursue bad actors. In 2022, the CCU sued or referred for investigation over 1,300 criminals in the U.S., UK, EU, and China. In this case, both Russell and Hawat attempted to use a "hidden links" scheme in which they posted links on their social media pages that directed their followers to seemingly generic product listing pages in the Amazon store. Russell and Hawat's co-conspirators disguised the infringing nature of the products they were selling in order to avoid detection by Amazon and the brand, often by blurring the brand's logo. Russell and Hawat's social media posts then made it clear to their followers that if they purchased these seemingly non-infringing and non-branded products, they would actually receive counterfeit luxury products. These bad actors also urged their followers to buy these products before Amazon could take down the listings.

09:22 EDT Clearmind Medicine enters collaboration with Johns Hopkins University - Clearmind Medicine has entered into a Clinical Trial Agreement with Johns Hopkins University School of Medicine to conduct its Phase I/IIa clinical trial of its proprietary MEAI-based CMND-100. The principal investigator, Jennifer Ellis, PhD, Associate Professor of Psychiatry and Behavioral Sciences, JHU School of Medicine will be supported by co-investigators Professor Eric Strain, Director, Behavioral Pharmacology Research Unit, JHU School of Medicine. The potential of psychedelic drugs to treat various neuropsychiatric indications is currently being explored in several human clinical trials. Clearmind's phase I/IIa trial, CM-CMND-001, the primary end point of the clinical trial is to find the tolerable dose and characterize the safety and pharmacokinetics/pharmacodynamics of single and repeated doses of CMND-100 in healthy subjects and those with Alcohol Use Disorder. The secondary end point is to evaluate the efficacy of CMND-100 in reduction of drinking patterns and cravings, in individuals with moderate-to-severe AUD. Oral capsules will be administered once daily, for ten consecutive days. The patients will report their drinking patterns and craving for alcohol during the clinical trial period. CM-CMND-001 clinical trial is a multinational, multi-center, Phase I/II single- and multiple-dose tolerability, safety and pharmacokinetic study in healthy volunteers and AUD subjects.

09:19 EDT Lucid Diagnostics releases data on clinical utility of EsoGuard - Lucid Diagnostics (LUCD), and majority-owned subsidiary of PAVmed Inc. (PAVM), announced it has released positive data from a retrospective analysis demonstrating real-world clinical utility of EsoGuard Esophageal DNA testing for the detection of esophageal precancer in a large cohort of fire fighters. The study documents 100 percent concordance between clinically directed EsoGuard test results and subsequent medical decision-making by the prescribing physician. It demonstrates that EsoGuard can efficiently test large populations at risk for esophageal precancer, allowing physicians to utilize EsoGuard results to appropriately triage those requiring confirmatory endoscopy in a manner broadly consistent with established, and recently updated, professional society guidelines. The manuscript, entitled Clinical Utility of EsoGuard as a Triage Test for Endoscopy to Identify Barrett's Esophagus in Fire Fighters, has been posted on the leading health sciences preprint server, medRxiv, pending peer review and publication. The release of these data closely aligns with and strongly supports recently proposed federal legislation seeking to fund guaranteed firefighter access to early detection tests such as EsoGuard. "These outstanding results of our first clinical utility study could not be more timely," said Lishan Aklog, M.D., Lucid's Chairman & Chief Executive Officer. "We have been gearing up to fully engage with payors for some time and are now armed with excellent clinical utility data and an expanding claims history to support these engagements. The timing aligns with our recent transition to an upgraded revenue cycle management provider, which continues to have a positive impact on claims processing, allowances, and collections.."

09:18 EDT Avantax welcomes CFS financial services - Avantax welcomes Comprehensive Financial Services, or CFS, a California-based financial services firm with more than $230M in total client assets as of May 15. The eight-person firm is led by Anna Luke, CFP and her husband Victor Luke; they transferred to Avantax from Independent Financial Group, or IFG. Anna Luke has grown a loyal client base by delivering extraordinary service with a disciplined financial planning approach that includes meeting often with clients, focusing on wealth preservation, and taking a personal approach to client care.

09:13 EDT Crexendo joins Webull Corporate Communications Service Platform - Crexendo announced that the Company has begun participating on the Webull Corporate Communications Service Platform. The Crexendo page on the Webull Platform will help provide the Company with a direct line of communication to shareholders and followers by providing up-to-date notifications regarding corporate content such as Company news, earnings reports, investor presentations, and more.

09:12 EDT Southwest sees Q3 RASM down 5%-7% vs. prior view of down 3%-7% - Sees Q3 ASMs up 12% y/y, with CASM-ex up 3.5%-6.5% y/y. In a regulatory filing, Southwest said "While August 2023 close-in leisure bookings were on the lower-end of the Company's expectations, modestly impacted by seasonal trends, overall leisure demand and yields continue to remain healthy. Travel demand during Labor Day weekend was strong and produced a record revenue performance for the holiday weekend. Managed business trends continue to perform in line with expectations, and the Company continues to expect overall corporate travel to have a modest underlying year-over-year sequential trend improvement in third quarter 2023 when compared with second quarter 2023. As a result, the Company continues to expect record third quarter operating revenues. The Company continues to deliver a solid operational performance. The Company's third quarter 2023 completion rate of approximately 99 percent, thus far, is in-line with expectations despite a challenging operating environment. Very strong daily operational performance has, thus far, offset the impact of roughly 1,400 cancellations from extreme weather-related disruptions, including hurricanes Hilary and Idalia, the Maui wildfires, and summer storm activity. As a result, the Company has not made any material revisions to its 2023 capacity plans compared with previous guidance. Furthermore, the Company does not expect the August 2023 weather-related disruptions to have a material impact on its third quarter 2023 financial results."

09:12 EDT Morris Sheet Metal awarded $5.1M in new contracts - Alpine 4 Holdings announces $5.1M in new contracts for a project headed by Stellantis Automobile Corporation and Samsung SDI. MSM's participation in this $2.5B project represents its initial contribution to a Lithium-ion battery plant and is expected to grow as the project advances into additional phases. The announcement comes as Morris Sheet Metal continues to report rising profit margins. This initial contract is for the mechanical installation for advanced production lines, and comprehensive HVAC safety measures that are compliant with national and international standards. This project has been designed for scalability to meet future market needs, leaving the door open for additional projects to be awarded to MSM.

09:11 EDT Applied DNA appoints Beverly Wolgast as executive director of Quality and cGMP - Applied DNA Sciences announced the appointment of Beverly Wolgast, as executive director of Quality and cGMP Programs. Wolgast will oversee and manage Applied DNA's quality assurance and control and regulatory compliance spanning the Company's three business segments, including implementing an ISO 13485-based quality management system for the scalable cGMP manufacture of LineaDNA. Wolgast brings to Applied DNA over 30 years of pharmaceutical and biotech experience in commercial and clinical-stage companies, with a proven track record of quality and regulatory compliance management and expertise in commercial biologics manufacturing operations.

09:10 EDT Upexi announces operational measures to monetize non-core assets - Upexi is announcing strategic operational measures to monetize non-core assets, reduce expenses and drive profitability. On August 31, 2023, Upexi entered into an Equity Interest Purchase Agreement pursuant to which the Company sold One hundred percent of the issued and outstanding equity of its wholly owned subsidiary Interactive Offers for $1,250,000, subject to certain customary post-closing adjustments. In addition, there is an obligation to pay Upexi 2.5% of certain advertising revenues of Interactive for a two-year period post-closing. On September 1, 2023, Upexi also exercised its option to acquire the remaining 45% of the issued and outstanding equity of Cygnet Online, LLC. As a result of the foregoing the Company now owns 100% of the issued and outstanding equity of Cygnet.

09:08 EDT PUR Water unveils collaboration with Beautiful by Drew - PUR Water, a Helen of Troy Limited brand, announced the launch of Beautiful by PUR, a collaboration with Beautiful by Drew, a brand created for beautiful living. A first-time collaboration for both brands, PUR and Beautiful by Drew have partnered to create a new line of water filtration products including PUR's fan-favorite pitchers, dispensers, and faucet mounts.

09:08 EDT Movella reduces number of employees by 20% - Movella Holdings announced that due to market conditions, on August 31, 2023, the Company reduced its number of employees by approximately 20%. The Company expects to substantially complete this workforce reduction in the third quarter of 2023. Additionally, the Company elected to restructure its operations by exiting certain non-core business activities. As a result of this workforce reduction and restructuring, the Company expects to incur a pre-tax cash charge for severance and restructuring costs which consists of one-time termination benefits and contract termination costs, of between approximately $1.1 million and $1.6 million in the third quarter of 2023. The Company expects to achieve cost savings of approximately $2.0 million per quarter following this action.

09:07 EDT WalkMe says NEC Corporation implements WalkMe in digital transformation - WalkMe announced that NEC Corporation has implemented WalkMe to drive the utilization of purchasing, procurement, and customer management systems as a part of its digital transformation initiatives. With WalkMe, NEC has improved business processes with a 75% reduction in employee support tickets, a 70% decrease in returned SAP Ariba submissions - all while boosting employee satisfaction and reducing support staff burden.

09:06 EDT Leidos chooses Casepoint as eDiscovery partner - Casepoint announced it has renewed its contract with Leidos to provide data collection, processing, and review services in support of the Centers for Medicare and Medicaid Services, CMS. Leidos began searching for a new eDiscovery platform last year. After conducting extensive research and testing on the top eDiscovery providers in the U.S., Leidos ultimately chose Casepoint as its new eDiscovery partner for a contract with CMS.

09:05 EDT Skechers sues Laforst Shoes for patent infringement - Skechers announced that it has sued Laforst Shoes for patent infringement of its proprietary Skechers Hands Free Slip-ins designs. The lawsuit was filed in the United States District Court for the Central District of California. In 2023, Laforst introduced a footwear style which incorporates multiple designs that infringe upon five separate Skechers patents for its Skechers Hands Free Slip-ins footwear.

09:04 EDT Equinix appoints Adam Berlew as Chief Marketing Officer - Equinix announced the appointment of Adam Berlew as Chief Marketing Officer, CMO, effective immediately. With more than 25 years' experience in strategic marketing and global leadership roles, Berlew returns to Equinix after previously serving as a Vice President of Global Marketing from 2012 to 2015. Berlew previously served as Head of Global Digital, Enterprise, Economy and Platform Marketing for Atlassian.

09:03 EDT IBM expands Cloud Security and Compliance Center - IBM announced the expansion of the IBM Cloud Security and Compliance Center, a suite of modernized cloud security and compliance solutions designed to help enterprises mitigate risk and protect data across their hybrid, multicloud environments and workloads. "IBM Cloud has a long history of working with clients in financial services and other highly regulated industries, especially when it comes to helping them to drive innovation while protecting their sensitive data," said Rohit Badlaney, General Manager, IBM Cloud Product and Industry Platform. "The expansion of the IBM Cloud Security and Compliance Center demonstrates our continued focus on industry-specific capabilities that help address real world business challenges for our clients."

09:03 EDT Silver Bull secures $9.5M litigation funding to pursue damages claim - Silver Bull Resources has secured funding for its international arbitration proceedings against the United Mexican States under the Agreement between the United States of America, Mexico, and Canada and the North American Free Trade Agreement. HIGHLIGHTS: Litigation Funding Agreement signed with Bench Walk Advisors to pursue international arbitration claims against Mexico for breaches of its obligations under NAFTA. The LFA facility is available for immediate draw down and provides funding to cover legal, tribunal and external expert costs and corporate operating expenses associated with the Company. US$9.5 million is provided as a purchase of a contingent entitlement to damages in the event that a damages award is recovered from Mexico. Legal counsel for the claim is Boies Schiller Flexner, an international law firm with extensive experience in international investment arbitration concerning mining and other natural resources, to act on its behalf. The BSF Team will be led by Timothy L. Foden, a noted practitioner in the mining arbitration space. The arbitration arises from Mexico's unlawful expropriation and other unlawful treatment of Silver Bull and its investments resulting from an illegal blockade of Silver Bull's Sierra Mojada project that began in September 2019 and continues to this day.

09:02 EDT IperionX, Heroux-Devtek partner for aerospace titanium recycling - IperionX and Heroux-Devtek have signed an agreement to underpin a 100% recycled titanium supply chain using scrap titanium metal from the aerospace industry. Heroux-Devtek specializes in the design, development, manufacture, and repair of landing gear, actuation systems and components for the global aerospace market. It serves both the commercial and defense aerospace sectors and is the third largest landing gear company in the world. Under this partnership, Heroux-Devtek will supply IperionX with Ti-6Al-4V alloy scrap metal generated from landing gear manufacturing. In turn, IperionX will employ its patented titanium processing technologies to convert this titanium scrap into low-carbon titanium for future applications. The processing of the Heroux-Devtek titanium scrap will be expertly managed by Aperam / ELG Utica Alloys, under their existing partnership with IperionX.

08:59 EDT Stereotaxis announces treatment with Genesis Robotic Magnetic Navigation System - Stereotaxis announced that physicians at Heart Centre Rigshospitalet of Copenhagen University Hospital successfully treated the first patients using Stereotaxis' Genesis Robotic Magnetic Navigation System. The Genesis system is the latest and most advanced robotic technology available for the treatment of heart rhythm disorders. Rigshospitalet is among the first in Europe, and the only hospital in Denmark, to offer the Genesis system to patients.

08:59 EDT PharmAla Biotech begins trading on OTCQB - PharmAla Biotech Holdings has qualified for trading on the OTCQB Venture Market in the United States operated by the OTC Markets Group Inc. and the Company's common shares commenced trading today on the OTCQB under the symbol "PMBHF". PharmAla's common shares will continue to trade on the Canadian Securities Exchange (under the ticker "MDMA".

08:58 EDT Network-1 Technologies reports results from Phase 2B study of BPZE1 vaccine - Network-1 Technologies announced that ILiAD Biotechnologies reported the first-ever demonstration of protection against B. pertussis colonization in a Phase 2b Human Challenge study of its BPZE1 vaccine. ILiAD announced that its BPZE1 intranasal pertussis vaccine has met the primary endpoint of protection against nasopharyngeal B. pertussis colonization in the Phase 2b CHAMPION-1 Study. To date, Network-1 has invested an aggregate of $7M in ILiAD which represents approximately 6.8% of the outstanding units of ILiAD on a non-fully diluted basis.

08:57 EDT Calian Group partners with MDA on Canadarm3 development - Calian Group has announced that Calian Advanced Technologies has been awarded a contract from MDA Inc. to support the development of Canadarm3, a next-generation space robotic system being developed by MDA for the Canadian Space Agency. Calian will develop and deliver the Electronic Ground Support Equipment for Canadarm3, Canada's contribution to the NASA-led Lunar Gateway. Calian will create the hardware and software solutions that will form the EGSE, known as System Test Centers and Unit Test Sets, which will be used to fully test the Canadarm3 prior to launch. MDA is the Prime Contractor for the Canadarm3 program that will operate aboard Gateway, a deep space outpost that will orbit the Moon. Gateway will support both human and robotic missions to the lunar surface, serving as a science laboratory, and acting as a proving ground for exploration missions into deeper space. Canadarm3 will be AI-enabled and comprised of a large and a small robotic arm, specialized tools to perform maintenance and science tasks, and robotic interfaces to enable access to all Gateway elements.

08:54 EDT Nine Brera players selected to represent their national teams - Brera Holdings announced that nine professional Brera players have been selected to represent their national youth teams. Of these, two hail from Brera Strumica in North Macedonia's First Division League, while the other seven belong to Brera Tchumene-a top team in Mozambique's Second League. Marko Alchevski, Brera Strumica's goalkeeper and captain of the North Macedonia Under-21 national team-who boasts four clean sheets in the first six League matchdays-will represent the team with winger Vane Krstevski in away matches in Sweden on September 8, followed by a home game against the Netherlands on September 12. Brera Tchumene's contributions to Mozambique's Under-20 selection include defenders Atilio Henriques, Aylton Messias, Shelton Zandamela and Cleyd Tropa, halfbacks Leonel Calcao and Julio Carrelo, as well as attacking midfielder Jose DJ Zavala. This ensemble will compete in compete in a friendly away game against neighbors Eswatini on September 6. Joining these Brera players on the national team is Hassane Rachide-coach of Brera Tchumene- who made his debut on the last matchday of the championship with a convincing 10-0 victory over Clube dos Amigos.

08:51 EDT DSS subsidiary appoints Jim Monaghan as COO and Chief Compliance Officer - DSS Wealth Management, a wholly owned subsidiary of DSS, and advisor to DSS AmericaFirst Quantitative Funds, announced that Jim Monaghan has joined as COO and Chief Compliance Officer and Michael Cheah has joined DSS Wealth Management in the role of Portfolio Manager & Head of Fixed Income. Jim Monaghan has joined DSS Wealth Management as COO and Chief Compliance Officer reporting to Daniel Lew. Monaghan has over 30 years working in the investment industry holding several leadership positions at industry leading financial firms. He started his career in the annuity business as an equity trader for pension funds at Mutual of America Life Insurance Company. Jim continued his career as an equity trader at Chase Bank working on their dealer trading floor on Wall Street. Jim's strong commitment to efficient operations, value added trading, and compliance earned him a leadership role in his next position as the Head of Trading and Operations for AIG's mutual fund company, SunAmerica Asset Management in New York City. His most recent position was at Bloomberg, specializing in compliance and trading platforms. Michael Cheah has joined DSS Wealth Management in the role of Portfolio Manager & Head of Fixed Income reporting to Daniel Lew, Chief Investment Officer, and Portfolio Manager of DSS Wealth. Cheah has more than 30 years of experience in the equity markets. Recently he was teaching Financial Markets and Responsibility, as well as Economic Data Analysis with Tableau at Fordham University.

08:49 EDT Metals Company announces next phase agreement with Kongsberg Digital - TMC the metals company announced that it had entered into the next phase of its relationship with Kongsberg Digital, a Norwegian leading software company that unlocks the value of data for customers within the maritime, energy, renewables, and power grid industries, to further develop the Digital Twin of the deep-sea operating environment of NORI Area D. Following the successful trials of the prototype Digital Twin during test mining conducted by TMC subsidiary Nauru Ocean Resources in 2022, the parties will now build upon the system's capabilities by incorporating additional data streams which will be used to train AI models to determine key outcomes of its full production system, including the environmental impacts of robotic collectors operating on the seafloor.

08:47 EDT Blink Charging announces donation of profits from UK chargers - Blink Charging announced that in recognition of World EV Day on September 9, it's wholly owned subsidiary, Blink Charging UK, will donate profits made from its UK chargers. Blink's participation aims to support efforts to reduce air pollution throughout the UK, emphasizing the significant positive effect EV adoption can have on air quality. Blink Charging UK will donate the proceeds to organizations working to eradicate lung diseases such as asthma. The donation will be based on the total amount of EV charging conducted on Blink UK's chargers throughout September 9th. The more drivers charge, the larger the donation. EV drivers can participate in the "Charge for Charity" initiative simply by charging their cars at a Blink charger on September 9th. Blink chargers can be found via the Blink Charging UK Mobile App Blink Charging UK.

08:45 EDT Enzo Biochem announces resignation of CEO Hamid Erfanian - Enzo Biochem announced that Hamid Erfanian, CEO, will be resigning his seat on the Board of Directors and departing the Company effective September 5 with Enzo's COO, Kara Cannon, assuming the role of interim CEO.

08:43 EDT Tingo Group issues response to statement by Hindenburg Research - Tingo Group issued a response to a statement made by short seller Hindenburg Research on September 5. The Company noted that Hindenburg has once again attempted to repeat its previous allegations despite the completion of a detailed investigation into the short-seller report of June 6 which disproved all such allegations. Stockholders are reminded of Hindenburg's disclaimers in its short seller report and subsequent statements. Having concluded the investigation into the allegations made by Hindenburg against the Company and its businesses, which was deemed to be the highest priority, the Company and its outside counsel will now proceed to investigate Hindenburg's allegations against the founder of Tingo Mobile and Tingo Foods, Dozy Mmobuosi.

08:42 EDT Taboola enters deal with Bright Mountain Media - Bright Mountain Media (BMTM) announced that its wholly owned subsidiary, Wild Sky Media entered into a deal with Taboola.com. Taboola announced a new partnership with Wild Sky Media, the largest portfolio of owned and operated parenting and family sites in the U.S. reaching 10 million unique visitors per month. Through this deal, digital properties for Wild Sky Media including Cafemom.com, Mom.com, Littlethings.com, and Mamaslatinas.com have incorporated Taboola recommendation widgets below their article pages, providing readers with personalized content, including sponsored options, for a more engaging experience. Additionally, Wild Sky Media is utilizing Taboola Newsroom, a technology offering that uses advanced A.I. and readership signals from more than 500 million daily active users. Newsroom helps Wild Sky Media further understand its audiences, learn about its most engaged articles and conduct A/B testing for headlines. Wild Sky Media has also adopted Taboola News, which integrates content recommendations from Taboola's large publisher network with leading mobile device manufacturers across multiple touchpoints, including Minus One screens, news notifications and browser applications. Lastly, Wild Sky Media has implemented Taboola's Explore More across its network, an offering designed to increase session depth and engage users visiting publisher sites directly from social media and apps.

08:40 EDT New York Community appoints Signorille-Browne as senior EVP, COO - New York Community Bancorp announced the appointment of Julie Signorille-Browne as Senior Executive Vice President, EVP, and Chief Operating Officer, COO. Signorille-Browne joined the Company in 2021 as Executive Vice President and Chief Administrative Officer and has more than three decades of experience in bank operations, process improvement, and M&A integration.

08:39 EDT FOXO Technologies announces agreement with Atrio Insurance - FOXO Technologies announced that its insurance distribution subsidiary, FOXO LIFE , has engaged Atrio Insurance/Singular Insurance Brokerage, an insurance brokerage general agency offering products and specialty programs throughout the United States, to sell Life Insurance Designed to Keep You Alive. This partnership will enable FOXO to expand its distribution footprint through Atrio/Singular's rapidly growing sales network of over 2,500 agents across 48 states. In selling life insurance complete with a FOXO Longevity Report , Atrio/Singular will add to its robust product portfolio, enhancing its ability to deliver comprehensive insurance solutions to clients. "Adding Atrio/Singular to FOXO LIFE's distribution hierarchy will allow us to sell life insurance designed to keep you alive in new and expanded markets," said Jim Grauel, Jr., Chief Distribution Officer of FOXO LIFE. "We are excited to add the energy and excitement Atrio Insurance/Singular Insurance Brokerage brings to the FOXO LIFE distribution team. We look forward to working and growing together." "We are extremely excited about this partnership with FOXO LIFE," said Jorge Acosta, CEO, Atrio/Singular Insurance "By combining our strengths, we are positioning ourselves to drive innovation; deliver exceptional value to our agents, brokers, and clients; and make a lasting impact in the Insurance and Insurtech industries. This partnership reflects our commitment to staying at the forefront of technological advancements and meeting the evolving needs of our clients. It's a significant step towards achieving our mutual goals. We will leverage our expertise to create solutions that exceed expectations and drive positive change in the life insurance industry."

08:38 EDT Arcos Dorados expands collaboration with UBQ Materials - UBQ Materials announced the expansion of its partnership with Arcos Dorados. Arcos Dorados has become the first UBQ partner to implement building components 'Made with UBQ.' The new electrical conduits, connection boxes, and modular wood boards will be showcased in Arcos Dorados' Sao Paulo-based restaurant conceptualized to showcase sustainability initiatives of the company. "When Arcos Dorados began the cooperation with UBQ Materials, we challenged the team to find applications to use UBQ throughout our McDonald's branches and supply chain. Our collaboration has been an important part of our approach to building sustainable operations and is setting a new standard for environmental responsibility in the restaurant sector," said Marie Tarrisse, Head of Social Impact and Sustainability at the Brazil Division of Arcos Dorados.

08:37 EDT Gyrodyne announces agreement with Star Equity Fund - Gyrodyne announced that it has entered into an agreement with Star Equity Fund, LP, under which Star Equity Fund has withdrawn both its slate of nominees for election at the 2023 annual shareholders meeting and its proposal regarding certain compensation matters, and Gyrodyne will freeze director fees and transition directors from its cash bonus plan to a new stock plan if approved by the shareholders. Under the terms of the agreement, Gyrodyne agreed to submit for shareholder approval at its 2023 annual shareholders meeting a new stock incentive plan for directors who currently participate in Gyrodyne's cash retention bonus plan. If shareholders approve the proposed stock plan, current director participants in the bonus plan will exchange their benefits for an equivalent value of shares under the new stock plan, with the shares vesting over a three-year period.

08:37 EDT Hanesbrands, Florida State sign multiyear partnership extension - HanesBrands and Florida State University announced they have signed a multiyear extension of their current apparel partnership that gives HanesBrands exclusive rights to Florida State fanwear in the mass retail channel. Additionally, the partnership includes collaborative retail activations marking key rivalries and events.

08:37 EDT Paranovus Entertainment signed a non-binding LOI to acquire BlueLine Studios - Paranovus Entertainment Technology announced that it has signed a non-binding Letter of Intent, LOI, to acquire 100% of BlueLine Studios, a portfolio company of Caravan Digital, a co-founder of consumer companies authentically powered by iconic artists and athletes in partnership with Creative Artists Agency. The deal is anticipated to close in the fourth quarter of 2023, provided that the parties reach a definitive agreement and the Company secures financing of at least $5 million. The completion of the deal is subject to customary approvals and closing conditions, including but not limited to satisfactory completion of due diligence and the Company's receipt of the payoff letters pertaining to certain indebtedness of BlueLine. Under the terms of the LOI, PAVS would acquire 100% of BlueLine's equity interests from Caravan and other equity owners of BlueLine. The consideration to be paid by the Company to purchase the equity interests is approximately $3.2 million in cash and unregistered Class A ordinary shares. Additionally, the Company will issue $1.11 million worth of its unregistered Class A ordinary shares to Caravan. Furthermore, the Company will issue $3.6 million worth of its unregistered Class A ordinary shares and $2.0 million worth of restricted stock units to a special purpose vehicle controlled by Mike Teh Wang, who represents BlueLine management. Finally, the Company will make a payment of $1.63 million in cash and unregistered Class A ordinary shares to the financial advisor for this Acquistion at the closing.

08:36 EDT Trust Stamp receives patent notices from USPTO - Trust Stamp announces that on August 29 it received a Notice of Issuance from the United States Patent Office in respect of Patent # 32742-149165 together with a Notice of Allowance on August 17 of Patent # 32742-1491643 both entitled "Systems and Processes for Lossy Biometric Representation". These patents will be the eighteenth and nineteenth issued to the company in addition to which the company has an additional twelve patent applications pending.

08:34 EDT Dominari Holdings releases shareholder update - Dominari Holdings released the following shareholder update: "As disclosed in prior letters and filings, Dominari has completed its transition from a drug development company to a financial services company, complete with a fully registered and rapidly growing broker-dealer subsidiary. With the first full quarter of operating a broker-dealer behind us, I am excited to take this opportunity to update you on our business and provide you with additional insights on how we intend to grow moving forward.... With our recent acquisitions, we currently hold over $700 million in client assets. We will continue to aggressively seek to grow the business through the acquisition of other wealth management teams with assets under management. Additionally, our budding capital markets team has already enjoyed success across a broad spectrum of industries, including in healthcare, biotechnology, industrial and consumer industries... As demonstrated above, we will continue to create a unique blend of traditional wealth management offerings that clients have come to know and trust. In addition, we are creating opportunities for our clients to participate in the leading edge of wealth creation vehicles via our access to pre-IPO companies and other unique alternative financial investments... Our leadership team is comprised of many seasoned veterans from leading Wall Street firms... As for Company structure, we have placed all of the legacy AikidoPharma business into a subsidiary, Aikido Labs LLC. Aikido Labs will continue to monitor and monetize the assets formerly held by AikidoPharma, such as the biotechnology assets and the Company'sholdings in other companies... Management strongly believes that the Company has created a solid platform from which to grow. As evidenced by our publicly filed Form 4s, members of the management team made multiple stock purchase transactions throughout the first, second and third quarters to demonstrate our belief in the Company. "

08:33 EDT Blue Star Foods receives a license renewal in South Carolina - Blue Star Foods announced that its soft-shell crab operations in South Carolina received a license renewal from the South Carolina Department of Natural Resources. The new license covers Blue Star as a wholesale dealer and wholesale dealer-peeler for crab and runs through June 2024.

08:32 EDT AMC Entertainment down 12% after disclosing equity distribution pact - AMC Entertainment shares are down $1.69, or 12%, to $11.95 in pre-market trading after the company disclosed that it entered into an equity distribution agreement with Citigroup, Barclays, B. Riley and Goldman Sachs as sales agents to offer and sell from time to time up to 40M shares of its Class A common stock.

08:30 EDT AMC Entertainment enters equity distribution pact for up to 40M shares - In a regulatory filing, AMC Entertainment stated: "We have entered into an equity distribution agreement with Citigroup Global Markets Inc., Barclays Capital Inc., B. Riley Securities, Inc. and Goldman Sachs & Co. LLC, as our sales agents, relating to the shares of our Class A common stock, par value $0.01 offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the Distribution Agreement, we may, through our sales agents, offer and sell from time to time up to 40,000,000 shares of our Class A common stock. The sales agents may act as agents on our behalf or purchase shares of our Class A common stock as principals. Sales, if any, of our Class A common stock, under this prospectus supplement and the accompanying prospectus may be made in sales deemed to be "at the market offerings" as defined in Rule 415 under the Securities Act of 1933, as amended, including by sales made directly on or through the New York Stock Exchange or another market for our Class A common stock, sales made to or through a market maker other than on an exchange or otherwise, in negotiated transactions at market prices prevailing at the time of sale or at negotiated prices, through a combination of any such methods of sale, or as otherwise agreed with the sales agents."

08:29 EDT Fortune Rise Acquisition announces Water On Demand deposited additional $100,000 - Fortune Rise Acquisition Corporation announced that Water On Demand, a privately-held subsidiary of OriginClear, and owner of its sponsor, Fortune Rise Sponsor, has deposited the required $100,000, representing an additional 27c per public share, into the Company's trust account for the benefit of its valued public stockholders which provides a one-month extension to complete the Company's initial business combination. This additional contribution extends the date by which the Company has to complete its initial business combination for an additional one-month extension from September 5, 2023 to October 5, 2023. The extension is the fifth of the six one-month extensions permitted under the Company's governing documents.

08:25 EDT Amdocs announces business momentum of 5G charging efforts - Amdocs announced business momentum of its 5G Charging efforts, allowing service providers to enable groundbreaking offerings and new monetization opportunities in the 5G-era. Historically, communications service providers have maintained many BSS platforms, supporting different lines of business with dated requirements. This limits their evolution, creating siloed environments for post-paid and pre-paid, fixed and mobile, 3G/4G and 5G, and more. In the 5G and cloud-native era, such silos are becoming unsustainable, and a new paradigm is required. Leveraging the power of 5G and cloud-native architecture, Amdocs Charging solves this issue, unlocking limitless monetization opportunities for advanced standalone 5G and beyond, propelling service providers globally into a new era of success, breaking down silos, and improving time to market and flexibility. Momentum includes: Amdocs currently has more than 20 cloud-based charging projects in production across a range of public, private, and hybrid environments, including at leading CSPs in North America. A recent implementation with a tier-1 service provider in Europe has been deployed in 4xActive, providing unprecedented reliability and a milestone for the communications and media industry. Globe Telecom is utilizing Amdocs Charging to modernize existing charging capabilities, speeding up time to market for new products and services. Amdocs Charging also allows API-based charging, allowing Globe to monetize digital and fintech services. Telefonica Moviles El Salvador selected Amdocs Charging allowing it to take advantage of new monetization opportunities enabled by 5G, and easily expand into additional countries over time using the same charging platform. In Amdocs' 5G Experience Lab, Amdocs Charging has played a critical role in enabling new monetizable case studies around enterprise services, gaming, IoT, and more, working with partners such as Microsoft.

08:23 EDT MaxCyte appoints Ali Soleymannezhad as Executive Vice President of Bioprocessing - MaxCyte announced the appointment of Ali Soleymannezhad as Executive Vice President of Bioprocessing, effective August 21. Soleymannezhad will lead global product development and marketing strategy for MaxCyte's bioprocessing business. The bioprocessing business is anchored by the STx and VLx platforms supporting biotherapeutic research, development and manufacturing using transient expression to produce complex proteins, vaccines and biologics at scale. Soleymannezhad brings almost 20 years of technical, sales and marketing expertise in biomanufacturing, bioprocessing and bioanalysis to his new role. Most recently, he served as Executive Vice President for the Separations and Purification business at Tosoh Bioscience overseeing a team of 140 employees across four global manufacturing, development, and commercial sites. During his tenure at Tosoh, Soleymannezhad was also Vice President of Global Marketing and Business Development and Director of Sales and Marketing Americas and served on the board of Semba Biosciences. Soleymannezhad received a Master of Business Administration in finance from Jones Graduate School of Business at Rice University in Texas after completing his Master and Bachelor of Chemical Engineering at University of Western Ontario's Faculty of Engineering in Canada.

08:22 EDT Bandwidth partners with Google, Cognigy to launch AIBridge - Bandwidth announced it is partnering with Google and Cognigy to launch AIBridge, which enables enterprises to easily deploy voice-based artificial intelligence tools in front of their contact centers-resolving calls faster and more efficiently in the communications cloud. Bandwidth AIBridge enables enterprises to resolve customer issues faster, which improves the overall customer experience and agent satisfaction while reducing contact center operating costs. With AIBridge, incoming calls to an enterprise contact center can first be routed directly to an AI-driven virtual agent, utilizing a pre-built integration with Bandwidth's Maestro platform.

08:21 EDT Hesai provides statement on 'misinformation in the market' - The company said, "Hesai is a publicly traded and privately owned company that began as a Silicon Valley lidar start-up in San Jose, California. It was founded in 2014 by two Stanford University engineering graduates and a University of Illinois Ph.D. Since then, Hesai has grown to become the global leader in designing, developing, and producing superior performing, high quality and safe lidar solutions for the Autonomous Mobility or robotaxis, Advanced Driver Assistance System for passenger cars, and last-mile delivery and industrial automation for robotics markets. Since its inception, Hesai has become the global leader, having shipped over 200,000 lidars to the AM, ADAS and robotics markets, including over 87,000 lidars in the first half of 2023 alone. Based on SEC filings and equity and industry research reports, for the full year 2022 and the first half of 2023, Hesai is the unequivocal market leader in terms of revenues and lidar units delivered. Hesai has established its leadership in the global lidar market while enjoying gross margins of more than 30 percent - the highest in the industry -- dispelling baseless allegations that Hesai sells lidars below cost to gain market share. Hesai's leadership in the lidar sector - with 47 percent of the global market share for automotive lidars - has been earned by designing and producing superior performing and higher quality lidar products as judged by the lidar marketplace. Intellectual Property Claims Brought by Ouster Innovation and safety are at the heart of Hesai's culture and practice. Hesai has more than 700 highly qualified engineers and staff working in its R&D and manufacturing teams who are dedicated to designing superior performing, high quality lidar products to advance the safety and performance of driver assisted technologies to save lives worldwide. This dedication and focus have resulted in superior lidar products based on over 400 granted patents and over 700 pending patent applications worldwide. On April 11, 2023, Ouster (OUST) filed a complaint against Hesai and Hesai Technology Co., Ltd. in the United States District Court for the District of Delaware for alleged patent infringement. At the same time, Ouster filed a companion complaint at the U.S. International Trade Commission, requesting an investigation into Hesai and its affiliated entities pursuant to Section 337 of the Tariff Act of 1930 based on substantially similar allegations. Hesai disputes and denies all of Ouster's allegations as baseless and lacking merit and is vigorously defending its IP and legal rights. The Delaware Action is currently stayed. On June 22, 2023, Hesai filed a motion to terminate the ITC Action. On August 24, 2023, the presiding Administrative Law Judge issued an order granting Hesai's motion to terminate the ITC Action. The order is an initial determination that is subject to review by the ITC Commissioners. Hesai values and respects valid and enforceable intellectual property rights and will continue to defend itself against any allegations that are improper or lack merit. Hesai Lidar Data Security Hesai lidar does not and cannot independently wirelessly transmit any operational or biometric data or data of any other kind. Hesai's lidar is a piece of hardware connected to a vehicle's computer via a secured cable on a nonstop, one-way information pathway. Hesai's lidars are analogous to the "eyes" of an autonomous vehicle securely transmitting information to the vehicle's computer, or "brain", which makes driving decisions. The vehicle's computers are entirely developed, owned, controlled, and operated by our customers. Once a Hesai lidar is sold to a customer, Hesai has no ability to access the images generated by the lidar, which does not have wireless connectivity and cannot be remotely operated or accessed. There is no so-called backdoor security risk. All of the images generated by our delivered lidars are controlled, operated, stored, accessed and used by our customers, not Hesai. Hesai lidars, based on their technical features, are not sensitive products that would involve national security concerns. They are civilian products by nature, and in addition, they are designed, developed and intended for sale solely for civilian, commercial purposes to advance the performance and safety of Autonomous Driving System with the objective of making transportation safer and saving lives worldwide. Hesai Ownership and Management Control Hesai is a privately founded and publicly traded company listed on Nasdaq. Hesai's ownership and management control are transparent and disclosed in our public SEC filings as a result of Hesai's recent $190 million February 2023 IPO on the Nasdaq. Our underwriters, auditors, and multiple American law firms have conducted extensive and thorough due diligence and vetting of Hesai's corporate and legal structure and finances. Hesai's IPO was underwritten by two leading American investment banks, Goldman Sachs and Morgan Stanley, and a leading European investment bank, Credit Suisse. The Company is audited by Deloitte, one of the Big 4 accounting firms. Furthermore, two leading American law firms have conducted extensive corporate and legal due diligence on Hesai. Hesai is transparently controlled by its Founders, international board of directors, and senior management team, with offices in China, the United States and Germany. Pre-IPO, Hesai was owned by the three Founders, employees, leading global private equity firms from Asia and the United States, and leading private international strategic investors in the automotive technology and TMT space from Europe and Asia."

08:20 EDT Clubhouse Media closes new promo deal with Keyshawn Johnson - Clubhouse Media Group announced that they have finalized a brand promotional deal with Keyshawn Johnson. "Keyshawn is a well-known name in the NFL and I'm excited we were able to bring this deal to the finish line" said a representative of CMGR. "Our agents are energized and the volume of deals is impressive heading toward Q4."

08:20 EDT Toast names Aman Narang as new CEO effective January 1 - Yesterday morning, the company "announced the appointment of Aman Narang as CEO, effective January 1, 2024. Narang has served as Toast's Co-President since December 2012 and Chief Operating Officer since June 2021. He will take over as CEO from Chris Comparato, who has served as the company's CEO since February 2015, leading Toast through a remarkable period of growth with a focus on profitability and operational excellence. Both Comparato and Narang will remain on the Board. Since co-founding the company in his basement in 2011 alongside Steve Fredette and Jonathan Grimm, Narang has been in instrumental leadership roles across the company as it scaled. Responsible for Sales, Marketing, and Business Development in Toast's early years, his role expanded over time to include the Customer Success organization, the Fintech line of business, Operations, and other critical functions and key initiatives. Prior to Toast, Narang worked in product management at Endeca, now part of Oracle."

08:18 EDT Hyundai Motor introduces in-vehicle payment service on new 2024 Kona - Hyundai Motor America is bringing in-vehicle payments to customers with the introduction of Hyundai Payi. The Hyundai Pay system allows customers to find and pay for things with their vehicle's touchscreen using securely stored credit card information. Hyundai has partnered with Parkopedia to launch Hyundai Pay's first service, a new parking payment system. "Hyundai Pay is the latest example of our continuous advancements in smart mobility and software-defined vehicles," said Olabisi Boyle, vice president, product planning and mobility strategy, Hyundai Motor North America. "With Hyundai Pay's scalable e-commerce platform, we can elevate customer convenience and extend their digital reach by making every day needs-like finding and paying for parking-easier, swifter and safer via our connected-car, integrated-cockpit and secure-transaction technology."

08:17 EDT Aemetis completes expansion of India biodiesel plant - Aemetis announced that the company's Universal Biofuels subsidiary has completed an expansion of its India biodiesel plant annual production capacity to 60 million gallons more than one year ahead of schedule, supplying the expanding demand for biodiesel by India government-owned Oil Marketing Companies. The Aemetis Five Year Plan describes an increase from 50 million gallons per year to 100 MGY of biodiesel production capacity at the India plant to be completed by year 2025. Additional capital projects to increase the production capacity at the Kakinada, India biodiesel plant to 80 MGY are in process for completion in the first half of 2024, also ahead of schedule. Built by Aemetis near the eastern India port of Kakinada in Andhra Pradesh, the Universal Biofuels plant is the largest biodiesel production facility in India. Expanded biodiesel production supports the Indian government's goal of a 5% biodiesel blend equal to approximately 1.25 billion gallons per year which was established in the 2022 National Biofuels Policy.

08:17 EDT SpartanNash promotes Morgan to EVP, Chief Merchandising Officer - SpartanNash announced the promotion of Bennett Morgan to Executive Vice President, Chief Merchandising Officer. Morgan joined SpartanNash in January 2022 as Senior Vice President, Chief Merchandising Officer. He leads fresh, center store and pharmacy merchandising, category management, pricing, promotions and master data management. Morgan's promotion follows the announcement of two newly appointed Merchandising leaders at SpartanNash - Arpen Shah as Vice President, Merchandising Strategy and Analytics, and Brandon Pasch as Vice President, Center Store Merchandising.

08:16 EDT ViaSat's Inmarsat Government awarded PLEO SBS contract by DISA - Viasat announced that Inmarsat Government, now part of Viasat, was awarded a Proliferated Low Earth Orbit, PLEO, Satellite-Based Services, SBS, contract by the U.S. Defense Information Systems Agency, DISA, on behalf of the U.S. Space Force's, USSF, Space Systems Command, SSC. Inmarsat Government is one of 16 companies selected for the $900 million ceiling, 10-year Indefinite Delivery, Indefinite Quantity contract. Under this contract, Viasat plans to leverage small satellite technology, reduced costs and increased launch service competition, facilitating the ability for pLEO constellations to provide persistent, global coverage with reduced transmission latency. "Viasat has a proud history of providing integrated SATCOM solutions and service offerings across multiple bands and orbits to support government customers' unique needs," said Susan Miller, President, Viasat Government. "Our team is committed to developing innovative, mission-focused solutions through our existing partnerships with satellite operators and extending opportunities with new partners. We eagerly look forward to using both our technologies and deep problem solving expertise to deliver resilient, robust and secure SATCOM capabilities to service members around the world."

08:15 EDT Duos Technologies Group names Christopher King as CCO - Duos Technologies Group announced the appointment of Christopher King as its new Chief Commercial Officer, effective August 30, 2023. Prior to joining Duos, he served in a series of progressive management roles within APR Energy.

08:14 EDT Stronghold Digital Mining mined 235BTC in August vs 225BTC in July - Stronghold Digital Mining provided the following updates regarding its operations and financial performance. In late August, Stronghold achieved hash rate capacity of 4 EH/s. As expected, 1,135 MicroBT Whatsminer M50 and M50S miners and 4,000 Canaan Avalon A1346 miners have been delivered, and all are either plugged in or expected to be plugged in imminently. The Company expects a considerable increase in hash rate in the month of September and over 20% hash rate growth in the Q4 when compared to the Q3. Stronghold mined 219 Bitcoin in August and generated approximately $0.5 million in energy revenue, which represents the equivalent of approximately 16 additional Bitcoin based on the average price of Bitcoin during the month. This equates to approximately 235 of Bitcoin-equivalent production in August compared to approximately 225 in July.

08:13 EDT VBI Vaccines partner announces topline data from BRII-179 study - VBI Vaccines announced that its strategic hepatitis B, or HBV, partner, Brii Biosciences, announced topline cohort-level unblinded Week 36 data from interim analysis of a randomized, placebo-controlled and double-blinded Phase 2 study of BRII-179, a Pre-S1/Pre-S2/S therapeutic vaccine, in combination treatment with pegylated interferon-alpha in chronic hepatitis B virus, or HBV, patients compared with PEG-IFNalpha only treatment. VBI and Brii Bio reported in previous studies that BRII-179 (VBI-2601) induced broad antibody and T-cell responses against Pre-S1, Pre-S2, and S epitopes in HBV patients. In July, VBI and Brii Bio announced an expansion of their HBV partnership to include an exclusive global license to develop and commercialize BRII-179, and an exclusive license to develop and commercialize PreHevbri, VBI's prophylactic 3-antigen adult HBV vaccine, in the Asia Pacific region, excluding Japan.

08:13 EDT ALX Oncology appoints Jason Lettmann as CEO - ALX Oncology Holdings announced that Jason Lettmann, a member of the Board of Directors, will succeed Jaume Pons as CEO, effective September 6. Pons will transition to the role of Chief Scientific Officer and remain President and both executives will remain members of the Board of Directors. Jason Lettmann has been involved with ALX Oncology for nearly a decade since its founding, having co-led the Company's first institutional financing and serving as a member of the Company's Board of Directors since 2015. Jason brings to the CEO post a broad suite of expertise relevant to ALX Oncology at its current stage of development including serving as CEO of Promedior, a biotechnology company developing targeted medicines to treat fibrosis.

08:11 EDT Tecsys announces collaboration with Magasin du Nord - Tecsys announces its recent collaboration with Magasin du Nord. "The successful modernization of logistics IT at Magasin du Nord is a testament to a solid strategic vision executed with technical precision," remarks Adam Krajewski, vice president of professional services at Tecsys. "By taking advantage of Omni OMS' composability, the team at Magasin du Nord architected benchmark order management capabilities that give them a true competitive edge in a today's retail ecosystem. We look forward to building on these successes as we deepen our partnership and find new opportunities to set the standard for omnichannel excellence."

08:10 EDT Lineage Cell in pact to discover iPSC line in deal with Eterna - Lineage Cell Therapeutics announced the initiation of certain development activities to generate a novel hypoimmune induced pluripotent stem cell or iPSC, line under the Company's exclusive option and license agreement with Eterna Therapeutics. This marks the next step under the strategic collaboration announced in February 2023, under which Eterna is developing innovative engineered hypoimmune iPSC lines that Lineage will evaluate for differentiation into cell transplant product candidates for central nervous system CNS diseases and other neurology indications. Since announcing the deal earlier this year, Lineage has evaluated its development strategy with a group of leading neurology experts in the U.S. and abroad. As a result of these and other discussions, and an assessment of the competitive landscape, Lineage finalized its selection of specific gene edits for the initial cell lines to be developed by Eterna...Lineage expects that these edits would expand the edited cell lines' overall utility, including for non-immune privileged or non-human leukocyte antigen matched indications and will further differentiate the cell line from others currently in use by competitors. "Our partnership with Eterna reflects an important step in a corporate strategy intended to capitalize on our existing process development capabilities by combining them with cutting-edge cell engineering and editing technologies, to create novel and potentially superior product profiles," stated Brian M. Culley, Chief Executive Officer of Lineage. "This collaboration reflects our effort to broaden the application of our cell therapy platform and our plans for future success in this growing field. ..The Agreement provides Lineage an option to obtain an exclusive license to utilize and sublicense the novel gene-edited cell lines developed by Eterna for preclinical, clinical, and commercial purposes in the field of CNS diseases. Eterna is the exclusive licensee of the key intellectual property underlying this collaboration from its discovery partner Factor Bioscience.

08:10 EDT Amneal receives ANDA approval from FDA for lisdexamfetamine dimesylate capsules - Amneal Pharmaceuticals announced it has received Abbreviated New Drug Application, or ANDA, approval from the FDA for lisdexamfetamine dimesylate capsules, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg.

08:08 EDT PepGen announces presentations of data on EDO platform - PepGen announced key highlights from the upcoming presentation of preclinical non-human primate, or NHP, data supporting PepGen's proprietary Enhanced Delivery Oligonucleotide, or EDO, platform at the 6th Ottawa International Conference on Neuromuscular Disease and Biology being held on September 7-9, Ottawa, ON, Canada, and at the 2023 Myotonic Dystrophy Foundation Annual Conference being held on September 7-9 in Washington, D.C. In a poster presentation titled "PGN-EDODM1 Nonclinical Data Demonstrate Mechanistic and Meaningful Activity for Potential Treatment of Myotonic Dystrophy Type 1" at MDF and "FREEDOM-DM1: Nonclinical Data Support the Phase 1 Study Design to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PGN-EDODM1 in Adults with Myotonic Dystrophy Type 1 " at NMD, PepGen reported that the EDO technology enables up to 25-fold higher level of nuclear delivery of oligonucleotides in vitro to myotubes compared to "naked" unconjugated oligonucleotides. Additionally, the presentation reported that EDO technology was also shown to improve in vivo nuclear delivery, with 72% of skeletal muscle nuclei in NHPs positive for oligonucleotide following two doses at 30mg/kg.

08:07 EDT Rumble Cloud launches beta release - Rumble announced the launch of the beta release of Rumble Cloud, ahead of the company's schedule. This launch marks a major milestone in creating a new infrastructure highway that will support the free and open internet. The Rumble Cloud will serve the significant share of the cloud market that is disenfranchised by Big Tech's censorship, as well as the significant share that is disenfranchised by Big Tech's unfair pricing and lock-in strategies. As part of its mission to protect a free and open internet, Rumble went public in late 2022, raising substantial capital to invest in content acquisition and build out independent infrastructure. Since then, Rumble and its growing team of world-class engineers have been actively building out infrastructure to support the company's high-growth video and streaming business. With the infrastructure in place to support its massive video requirements, Rumble is in a unique position to sell the excess capacity from this infrastructure into the cloud market while taking advantage of the economies of scale. Rumble Cloud will provide its beta customers with a robust portfolio of modern cloud services on the latest hardware and technologies. Its offerings will include cloud compute services such as virtual machines and Kubernetes, storage services including block and object storage, and networking services with load balancers and a virtual private cloud. The Rumble Cloud Beta Partner program will enable partners to enjoy the benefits of Rumble Cloud, provide critical feedback, and work side by side with top Rumble engineers.

08:07 EDT Check Point to acquire Atmosec, terms not disclosed - Check Point announced the acquisition of Atmosec. An early-stage start-up, Atmosec specializes in the rapid discovery and disconnection of malicious SaaS applications, preventing risky 3rd party SaaS communications, and rectifying SaaS misconfigurations. The move reinforces Check Point's commitment to enhance its SaaS security offering and address the security gaps and blind spots in SaaS applications. Atmosec was founded in January 2021 and employs 17 employees. The widespread adoption of SaaS applications has exposed organizations to an increased array of cyber threats. Statista reports an average use of 130 SaaS applications by organizations globally. Yet, Atmosec's research reveals that there are approximately 700 additional SaaS applications in use without IT's knowledge. Moreover, within popular enterprises SaaS platforms like O365 and Slack, hundreds of third-party apps are connected. This ever-expanding SaaS landscape not only increases the potential attack surface, but it also introduces many apps that could be harmful or misused to leak sensitive information, often bypassing proper IT authorization. Key features of Atmosec's technology include: Quick discovery and disconnection of malicious SaaS applications, completed in under 10 minutes; Prevent third-party SaaS applications from communicating with an enterprise's SaaS environment; Provide full visibility into authorized and unauthorized SaaS applications; Fix misconfigurations within SaaS applications such as publicly exposed repositories; Enforce multi factor authentication to access the application, and many more. With Atmosec's technology, Check Point Infinity will offer SaaS security with continuous SaaS posture management, prevention of malicious communications (SSPM), and a full security stack for SaaS apps including threat prevention, data protection, and adaptative zero-trust access controls for both users and devices. New capabilities will be incrementally released based on roadmap milestones, enabling organizations to utilize these critical enhancements from the same Check Point Infinity platform they already use today. The acquisition of Atmosec is expected to close by mid-September 2023.

08:06 EDT Bionano announces peer-reviewed publication on OGM and WES - Bionano Genomics announced a peer-reviewed publication from researchers at the German Cancer Consortium, or DKTK, showing the utility of optical genome mapping, or OGM, and whole-exome sequencing, or WES, in better understanding the mutational landscape of pediatric B-cell precursor acute lymphoblastic leukemia, or BCP-ALL. Researchers compared the analysis of 60 pediatric BCP-ALL samples using traditional cytogenetic methods against OGM and WES, finding that OGM and WES may provide novel insights into disease development and progression. Key takeaways include: OGM and WES identified 19 recurrently altered regions with novel potential leukemic drivers; OGM and WES identified double hits of structural variants, or SVs, and single-nucleotide variants, or SNVs, in the same sample, demonstrating the power of the combined approach of OGM and WES to identify compound events relevant to risk stratification and treatment of hematological malignancies; OGM identified 95% of SVs detected by karyotyping, or KT, fluorescence in situ hybridization and/or single nucleotide polymorphism array, including all hallmark translocations and chromosomal gains in hyperdiploid BCP-ALL.

08:04 EDT Amneal Pharmaceuticals announces Sevelamer carbonate approval in China - Amneal Pharmaceuticals announced it has received its first product approval in China. Sevelamer carbonate was approved and is expected to launch shortly. In addition, the company expects to launch oseltamivir phosphate in China this year as well, upon approval. In total, Amneal has six products pending review in China with more product registrations planned over time. Since 2019, the company has collaborated with Fosun Pharmaceuticals to bring key therapies to market in China.

08:03 EDT Cidara receives election to proceed notice for CD388 from Janssen - Cidara Therapeutics (CDTX) has announced that Janssen Pharmaceuticals, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (JNJ), has delivered to Cidara its Election to Proceed Notice for CD388, or JNJ-0953, which is being developed for the universal prevention of influenza A and B. Responsibility for future development, manufacturing and commercialization activities of CD388 will be assumed by Janssen, which intends to transfer its rights and obligations under the agreement to another entity. As part of its exclusive worldwide collaboration with Janssen, Cidara is studying CD388 in Phase 1 and 2a clinical trials evaluating safety and pharmacokinetics as well as efficacy as pre-exposure prophylaxis against an influenza virus in healthy volunteers during a human challenge study. Earlier this year, Cidara announced promising interim efficacy and safety data from the Phase 2a study. The interim analysis demonstrated that a single dose of CD388 decreased viral replication in the upper respiratory tract and lowered influenza incidence rate compared to placebo. Cidara will receive a $7M milestone payment from Janssen for the election to proceed for CD388 and other influenza DFCs. Under the collaboration agreement, Cidara is eligible to potentially receive an additional $685 million in development, regulatory and commercial milestones, plus tiered royalties on worldwide sales.

08:00 EDT Aurora Cannabis partners with Brazilian company to expand CBD portfolio - Aurora Cannabis announced an expansion of its hemp-derived CBD portfolio into Brazil. In partnership with Herbarium, the leading Brazilian company in herbal medicine, Aurora will launch the company's full-spectrum, single-source 3% CBD oil, under the Herbarium brand. "We are proud to continue our international expansion and bring quality CBD products to Brazilians alongside our partner, Herbarium, a trusted brand in the market," says Andre Jerome, EVP of Global Business Development at Aurora Cannabis. "Brazil has strong growth potential, and we look forward to leveraging our leadership in the market to further unlock key opportunities in South America

07:59 EDT Barrick Gold ceases to be insider of Cascadia Metals - Barrick Gold announced that following the August 24, 2023 closing of a private placement of units by Cascadia Minerals, Barrick's 2,788,696 common shares of Cascadia represent approximately 7.6% of Cascadia's outstanding common shares. Barrick did not acquire any securities in the Private Placement and, as a result of the Private Placement, Barrick has ceased to be an insider of Cascadia pursuant to Canadian securities laws. Barrick is holding its Cascadia common shares for investment purposes. Depending on market conditions and other factors, including Cascadia's business and financial condition, Barrick may acquire additional common shares or other securities of Cascadia or dispose of some or all of the common shares or other securities of Cascadia that it owns at such time.

07:46 EDT Aptose Biosciences closes $3M investment by Hanmi - Aptose Biosciences announced closing of a $3 million investment in common shares of the Company as the first tranche of a private equity investment for up to a maximum of $7 million or 19.99 percent ownership interest by Hanmi Pharmaceutical, Seoul, South Korea. Under the terms of the strategic investment, Hanmi purchased each Share at a price of $4.488, representing a premium over Aptose's common stock price. The investment will provide additional financing for Aptose's lead hematology drug, tuspetinib, formerly HM43239, which was licensed from Hanmi in November 2021 and is currently in the APTIVATE international Phase 1/2 expansion trial in which patients with relapsed or refractory acute myeloid leukemia receive tuspetinib monotherapy or in combination with venetoclax. Aptose has granted Hanmi certain rights pursuant to an investor rights agreement, including registration rights, pre-emptive rights, information rights and the right to appoint non-executive consultants. The closing of the second tranche for up to $4 million or a maximum of 19.99 percent ownership interest will be triggered upon Aptose achieving, prior to July 1, 2024, certain manufacturing and data milestones related to tuspetinib. The Company currently anticipates achieving the milestones by year-end. Under the second tranche of the investment, Hanmi may not acquire more than 19.99% of the Shares issued and outstanding calculated as of the closing date, and, if necessary, the proceeds from the second tranche will be reduced to the extent exceeding this limit irrespective of the Company achieving the milestones.

07:43 EDT Beamr Imaging announces second beta release of video optimization service - Beamr Imaging announced the second beta release of its cloud service for video optimization, introducing new APIs that empower customers to automate large-scale video optimization in the cloud. Beamr is focusing on optimizing public cloud video storage, which is projected to reach a value of USD 13.5 billion by the end of 2025. In Beamr's IPO, which was completed in March 2023, Beamr unveiled a 12-month roadmap. Initially, Beamr announced an integration with Nvidia NVENC technology, offering up to a 10x performance improvement over CPU-based solutions. Nvidia later published a blog post highlighting the impressive results achieved through this collaboration between Nvidia and Beamr.

07:41 EDT CorVel launches CorVel University - CorVel Corporation announced the launch of CorVel University, a comprehensive national training initiative designed to equip candidates with the necessary skills and knowledge to excel as claims specialists in various jurisdictions. Each session will last four weeks. Classes will be taught by experienced CorVel executives and specialists in a combination of in-person and remote sessions. The curriculum will include: An in-depth examination of workers' compensation claims administration, including regulatory and jurisdictional compliance, types of claims, the life cycle of a claim, special handling, and performance standards for claims management. All aspects of CorVel products and services, including how integration produces more accurate processing and outcomes and how the various teams collaborate to deliver a holistic claims management approach. The principles and practices that are unique to the CorVel culture.

07:40 EDT PharmaTher submitts ANDA for KETARX to FDA - PharmaTher Holdings announced it has submitted a priority original Abbreviated New Drug Application, or ANDA, for KETARX, or racemic ketamine, to the FDA for expedited review of its ANDA. The Company anticipates KETARX approval and commercial launch in the U.S. in Q2-2024, followed by the pursuit of international approvals to support the growing global demand for ketamine. Ketamine is an essential medicine used for anaesthesia and analgesia listed on the WHO Essential Medicines List. Ketamine has been on the FDA's drug shortage list since February 2018.

07:38 EDT Cytokinetics opens enrollment for ACACIA-HCM - Cytokinetics announced that ACACIA-HCM, or Assessment Comparing Aficamten to Placebo on Cardiac Endpoints In Adults with Non-Obstructive HCM, a Phase 3 clinical trial of aficamten in patients with symptomatic non-obstructive hypertrophic cardiomyopathy, or nHCM, is open to enrollment. Aficamten is a next-in-class cardiac myosin inhibitor in development for the potential treatment of HCM. ACACIA-HCM is a Phase 3, multi-center, randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effect of aficamten compared to placebo on health-related quality of life in participants with symptomatic nHCM. The primary endpoint is the change in Kansas City Cardiomyopathy Questionnaire, or KCCQ, Clinical Summary Score from baseline to Week 36. Secondary endpoints include the change from baseline to Week 36 in maximal exercise performance and sub-maximal exercise performance, the proportion of patients with greater than or equal to1 class improvement in New York Heart Association functional class, changes in left atrial volume index and NT-proBNP. After the primary analysis at 36 weeks, patients will continue treatment with aficamten or placebo for up to 72 weeks to evaluate additional secondary and exploratory analyses including the time to first cardiovascular event.

07:37 EDT nCino enhances Small Business Banking Solution - nCino announced enhancements to its Small Business Banking Solution. The updates allow for relevant data to be captured as a part of the loan origination workflow across a financial institution's portfolio and subsequently exported for Dodd-Frank 1071 compliance. nCino's Small Business Banking Solution adapts to an ever-changing regulatory landscape, allowing institutions to expand their portfolio, capture relevant demographic data, and stay ahead of regulation deadlines. As additional regulatory milestones approach or evolve, nCino will continue to release updates and enhancements affording financial institutions time to fine-tune processes and help ensure compliance.

07:36 EDT Biogen appoints Jane Grogan as Executive Vice President - Biogen announced the appointment of Jane Grogan, as Executive Vice President, Head of Research effective 2 October. Grogan will be a member of Biogen's Executive Committee reporting to Christopher A. Viehbacher, President and CEO. Jane Grogan brings nearly two decades of experience leading biotech research, including fifteen years with Genentech. Grogan most recently served as the Chief Scientific Officer at Graphite Bio, a cell and gene editing company. Prior to this, she served as Chief Scientific Officer at ArsenalBio, a privately held programmable T cell therapy company, responsible for research, discovery and preclinical pipeline, including development for the company's first product candidate.

07:35 EDT Aramark Board approves spin-off of Vestis - Aramar announced that its Board of Directors approved the previously announced tax-free spin-off transaction of its uniforms and workplace supplies business, which will be named Vestis. The spin-off is expected to be completed on September 30 , and will be effected through a pro rata distribution of the common stock of Vestis Corporation. Holders of Aramark common stock will be entitled to receive one share of Vestis common stock for every two shares of Aramark common stock held as of the close of business on September 20 , the record date for the distribution. No stockholder action is necessary to receive shares in the distribution of Vestis common stock. Aramark stockholders who hold Aramark common stock on the record date will receive a book-entry account statement reflecting their ownership of Vestis common stock or their brokerage account will be credited with Vestis shares. Because September 30 is a Saturday and not a business day, the shares are expected to be credited to "street name" stockholders through the Depository Trust Corporation on the first trading day thereafter, October 2.

07:34 EDT Exro Technologies announces coil driver start of production - Exro Technologies (EXROF) announced a significant corporate milestone with the official start of production of the company's patented Coil Driver technology. The milestone is backed by purchase orders from Italian OEM supplier HB4 Group and Canadian electric bus and commercial vehicle manufacturer Vicinity Motor Corp (VEV). "On behalf of everyone at Exro, we are thrilled to announce the official start of production of our Coil Driver technology", said Exro CEO Sue Ozdemir. "This achievement marks a tremendous milestone in bringing our next-generation technology to market from proof-of-concept on paper over three years ago, to now being in production for on-road customer vehicles."

07:32 EDT Saia reports August LTL shipments per workday up 14.2% from last year - Saia provided LTL shipment and tonnage data for July and August. In July 2023, compared to July 2022, LTL shipments per workday increased 6.0%, LTL tonnage per workday increased 3.4% and LTL weight per shipment declined 2.4% to 1,401 pounds. In August, compared to August 2022, LTL shipments per workday increased 14.2%, LTL tonnage per workday increased 6.8% and LTL weight per shipment declined 6.4% to 1,339 pounds.

07:30 EDT Unicycive Therapeutics appoints Sara Kenkare-Mitra to board of directors - Unicycive Therapeutics (UNCY) announced the appointment of Sara Kenkare-Mitra, to the Company's Board of Directors, effective September 6. As a veteran of the biotech and pharmaceutical industry, we believe Sara's leadership and experience in drug development spanning more than 25 years will significantly help bolster Unicycive's future growth. Sara Kenkare-Mitra, is currently President and Head of Research and Development at Alector (ALEC) where she leads all aspects of the company's R&D efforts in neurodegeneration, including oversight of the research, development, clinical, manufacturing, regulatory, and related functions. Prior to joining Alector, Kenkare-Mitra held roles of increasing responsibility at Genentech over the course of 23 years serving most recently as Senior Vice President, Development Sciences in Genentech's research and early development unit. During her tenure at Genentech, she led a large, integrated global organization of approximately 650 employees, and played a key role in the filing of more than 100 Investigational New Drug/clinical trial applications around the world, and the approval of 11 medicines for diverse diseases, including cancers and neurological diseases. Her team also enabled the successful development and approval of over 15 companion diagnostics.

07:28 EDT Iris Energy reports negative electricity costs in August - Iris Energy published a monthly investor update for August, containing its results from operations as well as business updates. Reports: Negative realized electricity costs of ~$0.08/kWh3; Company was effectively paid ~$28k per Bitcoin to take power at Childress and generated a further ~$28k per Bitcoin in mining revenue; 580MW of additional power available at Childress for expansion. Initial purchase of 248 NVIDIA H100 GPUs for ~$10M; Bitcoin mining remains core; next-gen compute represents additional opportunity; Childress construction; Mass grading civil works complete, data center concrete foundation works commenced; Construction remains on track for 20MW to 100MW expansion; Supports hashrate growth from 5.6 EH/s to 9.1 EH/s6.

07:27 EDT Tenon Medical announces first patients treated with JIB instrument kit - Tennon Medical announced completion of the first patients treated with the Company's newly released JIB Instrument Kit. Matthew T. Davies, MD, a board-certified Neurosurgeon from Orthopedic Associates in Duluth, Minnesota successfully treated the first three patients with the JIB kit at Lakewalk Surgery Center on August 31, 2023. Dr. Davies is a recognized leader in the diagnosis and treatment of the SI Joint, utilizing innovative minimally invasive SI Joint fusion procedures to treat painful SI Joint dysfunction and degenerative sacroiliitis. He has performed more than 300 SI Joint fusion procedures and recently incorporated the Catamaran implant into his SI Joint fusion treatment algorithm.

07:25 EDT Correction: BioCardia provided update on its CardiAMP cell therapy programs - BioCardia announced a clarification and next steps on its autologous CardiAMP cell therapy programs. Based on the recent interim results in the CardiAMP autologous cell therapy for the treatment of heart failure, or BCDA-01, the Company is exploring development of a new Phase III clinical trial protocol. The Finkelstein Schoenfeld, or FS, primary composite endpoint used in the CardiAMP HF Trial has tiers of outcomes in decreasing order of importance: heart death equivalent, major adverse cardiac and cerebrovascular MACCE, and Six Minute Walk Distance, or 6MWD. Since the primary FS endpoint is a composite of these elements, meeting the FS endpoint may be met even if one or more of the components does not individually demonstrate statistical significance. This has implications for the future trial design. The CardiAMP HF Trial interim results showed that the first two most important tier outcomes, occurring in 30% of the study patients, could have contributed sufficiently toward efficacy given a longer follow-up period than one year. If these interim results are replicated in a future study in which the third tier 6MWD is replaced with a more objective endpoint, there may be a pathway to a successful trial for product registration in the U.S. The FDA has previously expressed a preference for replacing the 6MWD with Cardiopulmonary Exercise Testing, which is a more objective outcome.

07:23 EDT Trevena receives $15M non-dilutive tranche - Trevena announced receipt of a $15 million tranche under its non-dilutive ex-US royalty-based financing. This tranche of funding was triggered by the first commercial sale of OLINVYK in China by Jiangsu Nhwa, the Company's licensee in China. As previously announced, OLINVYK has been approved in China for use in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. The $15 million tranche is in addition to the $28.1 million of cash and cash equivalents the Company previously reported as of June 30, 2023. As part of the R-Bridge Financing, Trevena may receive an additional $10 million upon achievement of either a commercial or financing milestone. The Company also announced additional expected near-term milestones: New VOLITION Respiratory Data for OLINVYK. The Company previously reported initial topline GI and delirium data from the ~200 patient OLINVYK VOLITION study, a real-world, open-label, multi-site study led by clinical outcomes research experts from Cleveland Clinic and Wake Forest Baptist Health Medical Center. Trevena expects to report new respiratory data from the study using continuous respiratory monitoring in 3Q 2023. OLINVYK Abstracts Accepted at American Society of Anesthesiologists 2023 Meeting. The Company has three abstracts accepted for presentation at ASA, which will be held in San Francisco from October 13th to the 17th. One abstract was selected for an oral presentation as a top research abstract. The abstracts are embargoed until the conclusion of the meeting and at which time they will be available at https://www.trevena.com/publications. "ARTEMIS, A Real-World Evidence Trial Examining the Use of Oliceridine, a Biased Agonist at the mu Receptor, in Patients Requiring Post-Surgical Pain Control." With lead author Todd L. Wandstrat, PharmD of Trevena, Inc. "Postoperative Vomiting With IV Oliceridine in Postoperative Recovery: A Single-group Prospective Cohort Study" with lead author Mark Demitrack, M.D of Trevena, Inc. "Antinociception Versus Neurocognitive Effect of Biased Mu-opioid Receptor Oliceridine Versus Morphine- Utility Function Analysis" with lead author Albert Dahan MD PhD of the Centre for Human Drug Research, Leiden, the Netherlands. TRV045 Data. The Company today reported results from its Target Engagement and TMS Proof-of-Concept studies. In addition, a nonclinical study of TRV045 is ongoing, focused on the potential of TRV045 to treat infantile spasms, a rare pediatric disorder. TRV045 is also being studied by the NIH's Epilepsy Therapy Screening Program as a potential disease-modifying therapeutic for the prevention of seizures. Nonclinical data from both of these studies are expected 2H 2023.

07:20 EDT NaaS secures RMB 204M energy storage order - NaaS Technology announced that it has signed strategic cooperation agreements with several enterprises through its subsidiary Nengcang Technology. Under the agreements, NaaS will supply over 380 charging stations with energy storage equipment while offering comprehensive solutions, boasting an energy storage capacity of 130.088MWh. The total order value is RMB204 million, with implementation set for the coming months. "We are thrilled to embark on this strategic cooperation with our prominent partners, a testament to the recognition of NaaS' operating capabilities and business model in seamlessly integrating energy storage solutions at charging stations," stated Ms. Yang Wang, founder and CEO of NaaS. "According to the NaaS Research Institute, China's charging stations will grow to 1.8 million in the next decade, requiring a 637GWh of energy storage capacity, with total investment expected to exceed RMB1 trillion. Consequently, by propelling the growth and maturation of photovoltaic-storage-charging station development, we are redefining the energy landscape. We strongly believe that this collaboration will not only drive our growth but also have far-reaching exemplar effects that are poised to resonate throughout the industry in the times ahead."

07:20 EDT Viking Therapeutics announces initiation of Phase 2 VENTURE trial - Viking Therapeutics announced the initiation of a Phase 2 clinical trial of VK2735, the company's wholly-owned dual agonist of the glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide receptors. VK2735 is in development for the potential treatment of various metabolic disorders such as obesity. The Phase 2 VENTURE trial is a randomized, double-blind, placebo-controlled study that will evaluate the safety, tolerability, pharmacokinetics, and weight loss efficacy of four different doses of VK2735, administered subcutaneously, once weekly.

07:18 EDT Orgenesis appoints Gerhard Bauer as VP of Global Product Implementation - Orgenesis appointed Gerhard Bauer as the Vice President of Global Product Implementation at Octomera has been made to enhance the existing process development, regulatory, engineering, equipment, and data/technical service offering and POCare Center hubs. He is also an active contributor to the evolution of the flexible facilities format, Octomera Mobile Process Labs & Units, or OMPULs, and network, which allow the traditional facility build time to be cut down from years to under 6 months.

07:17 EDT Iridium provides global connectivity for XCMG heavy equipment - Iridium Communications announced that Xuzhou Construction Machinery Group will deploy Iridium IoT services on its global fleet of heavy equipment, starting with excavators and expanding to loaders and crane trucks as needed. XCMG will utilize Iridium's global network to maintain critical connectivity with their heavy equipment in key strategic locations including Australia, Southeast Asia, Latin America, Africa, and Central Asia. "As a world class OEM, XCMG continues to demonstrate their forward-thinking approach and innovation in the heavy equipment industry," said Matt Desch, CEO, Iridium. "By leveraging Iridium's truly global, weather-resilient satellite connectivity on their machinery, XCMG is enabling a better user experience with advanced, cutting-edge solutions to their customers worldwide."

07:16 EDT Eledon announce publication fo study evaluating tegoprubart - Eledon Pharmaceuticals announced the publication of a study evaluating tegoprubart as an immunomodulatory monotherapy in nonhuman primate kidney and islet allotransplants. The study, entitled "The anti-CD40L monoclonal antibody AT-1501 promotes islet and kidney allograft survival and function in nonhuman primates", was published in the August 30, 2023, issue of Science Translational Medicine. Results from the study showed that treatment with tegoprubart as a monotherapy promoted long-term kidney and islet allograft survival and function in nonhuman primates, indicating its potential as an immunomodulatory agent for organ transplantation. In the study, tegoprubart did not bind to Fc receptors or promote platelet aggregation in vivo, thereby minimizing the risk of thromboembolic complications, while also retaining a high binding affinity to CD40L. Additionally, phenotypes of both CD4+ and CD8+ cells remained similar throughout the study. Eledon recently initiated the BESTOW study, a phase 2 study enrolling approximately 120 participants undergoing kidney transplantation to assess the efficacy and safety of tegoprubart compared to the standard of care.

07:16 EDT Kodiak Gas Services added to four Russell US indexes - Kodiak Gas Services announced that it will be added to the Russell 2000, Russell 2500, Russell 3000 and Russell Small Cap Completeness indexes as part of the Russell Indexes' planned third quarter IPO additions. Kodiak is scheduled to be added to these indexes after equity markets close on September 15, 2023 and is expected to begin trading as a component of these indexes when equity markets open on Monday, September 18, 2023. Mickey McKee, Kodiak's founder and Chief Executive Officer, stated, "Kodiak's inclusion in these Russell indexes marks another meaningful milestone following our successful IPO earlier this summer and will significantly broaden our visibility among the investment community. We are excited to further expand our shareholder base to include a greater number of passive and active ETFs and institutions."

07:15 EDT Yunji appoints Chen as independent director, Xi resigns from positions - Yunji announced the appointment of Xuefeng Chen as an independent director of the Company, effective September 6, 2023. Suqin Xi has concurrently resigned from his position as an independent director and no longer serves as a member on the audit committee, compensation committee, and nominating and corporate governance committee of the Company's board of directors. Xuefeng Chen will serve as a member on each of these committees.

07:15 EDT Enthusiast Gaming, Netflix, Metavision partner for Fortnite Creative experience - Enthusiast Gaming Holdings and Metavision have collaborated with Netflix to launch its first-ever Fortnite Creative experience for the most popular manga series in history: ONE PIECE, in celebration of the new live-action version streaming globally on Netflix beginning August 31. The in-game experience, created with the new development toolbox 'Unreal Editor for Fortnite' in Fortnite Creative, a tool that allows users to design, create and share experiences with other players outside of the traditional 'Battle Royale', marks the first time that a streaming service has utilized the platform's creative capabilities to deliver a bespoke gaming experience to fans.

07:14 EDT Tonix Pharmaceuticals plans to meet potential increased demand for Tosymra - Tonix Pharmaceuticals Holding (TNXP) announced that it is committed to meeting potential increased demand for Tosymra, or sumatriptan, nasal spray 10 mg after GlaxoSmithKline's (GSK) planned discontinuation of Imitrex, or sumatriptan, nasal spray 5 mg and 20 mg products after January, 2024. Drug shortages have presented an ongoing challenge for the U.S. healthcare system, reaching near-record levels2 in recent months, causing treatment delays and rationing. Tonix is ready to step in to alleviate potential shortages in sumatriptan, a widely used treatment option for acute migraine.

07:12 EDT Myriad Genetics announces results of survey on ovarian cancer screening - Myriad Genetics revealed new nationwide survey results indicating widespread confusion and misconceptions about ovarian cancer screening among a majority of women. The Myriad Genetics Cancer Risk survey shows that nearly three out of four women falsely believe annual pap smears include testing for ovarian cancer. According to the Centers for Disease Control and Prevention, the "only gynecologic cancer the Pap test screens for is cervical cancer." While almost half of the women surveyed believe they are being proactive when it comes to ovarian health, only 38% say they visited an OB-GYN in the past year and 13% say they have taken a genetic test to assess risk for cancer. For those who have not taken a genetic test, many women said they'd be motivated to get a genetic test if they had a high-risk of ovarian cancer based on family medical history or an immediate family member with ovarian cancer. Regardless of risk factors, 71% of the women surveyed believe all women should have genetic testing to determine ovarian cancer risk. Two out of three agree that knowing their risk will allow them to take more appropriate preventative measures and 58% agree knowing their risk will help their doctor more appropriately plan treatment should they get cancer.

07:11 EDT Tango Therapeutics receives clearance from FDA for TNG348 - Tango Therapeutics announced that the FDA has cleared the Company's Investigational New Drug, or IND, application for TNG348, a novel inhibitor of USP1, or ubiquitin-specific protease 1, for the treatment of BRCA1/2 mutant and other HRD+ cancers. "FDA clearance to start the TNG348 phase 1/2 clinical study is an important step in the development of a novel treatment with the potential to treat a substantial number of ovarian, prostate and breast cancers. We plan to initiate the TNG348 clinical trial in the first half of 2024," said Barbara Weber, President and CEO of Tango Therapeutics. The phase 1/2 clinical trial will evaluate the safety, pharmacokinetics, pharmacodynamics and efficacy of TNG348 as a single agent and in combination with olaparib, a PARP inhibitor, in patients with BRCA1/2-mutant and other HRD+ cancers. HRD+ cancers, including BRCA1/2 mutations, represent up to 50% of ovarian cancers, 25% of breast cancers, 10% of prostate cancers and 5% of pancreatic cancers.

07:09 EDT Trevena receives $15M tranche under its ex-US royalty-based financing - Trevena announced receipt of a $15M tranche under its non-dilutive ex-US royalty-based financing. This tranche of funding was triggered by the first commercial sale of OLINVYK in China by Jiangsu Nhwa, the Company's licensee in China. As previously announced, OLINVYK has been approved in China for use in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. This tranche is in addition to the $28.1M of cash and cash equivalents the Company previously reported as of June 30, 2023. As part of the R-Bridge Financing, Trevena may receive an additional $10M upon achievement of either a commercial or financing milestone. The Company also announced additional expected near-term milestones:

07:09 EDT GlycoMimetics doses first cohort in GMI-1687 study - GlycoMimetics announced dosing of the first cohort of healthy volunteers in a Phase 1a study of GMI-1687 to evaluate safety, tolerability, and pharmacokinetics.

07:08 EDT General Mills sees Q1 Pet segment organic net sales 'to be roughly flat' YoY - "As in human food, retail sales trends in the U.S. pet food category have been moderating recently, driven in part by less impact from pricing. With U.S. pet parents increasingly cautious about their economic outlook, some have been shifting toward more value-oriented products and channels as well as smaller pack sizes. In addition, pet parents spending more time away from home has negatively impacted the treats and wet food segments of the category. As a result of these more challenging category dynamics, the company now expects first-quarter fiscal 2024 Pet segment organic net sales to be roughly flat versus last year and segment operating profit margin to be approximately 19 percent. While Pet segment volume trends are expected to remain challenged in the months ahead amid a more difficult short-term U.S. pet food category dynamic, the company continues to see strong long-term growth opportunities for Blue Buffalo as the multi-decade trend toward humanization continues.," said the company in the release.

07:08 EDT Ceva announces its RivieraWaves Bluetooth 5.4 Platform is SIG qualified - CEVA announced that its RivieraWaves Bluetooth 5.4 Platform is SIG qualified and already licensed to several customers, including to those addressing the rapidly expanding Electronic Shelf Label market. Global technology intelligence firm ABI Research forecasts that the ESL market will grow from nearly 185 million annual shipments in 2022 to nearly 560 million units by 2027, with Bluetooth-enabled ESLs accounting for a growing portion of the overall market. Tal Shalev, Vice President and General Manager of the Wireless IoT BU at CEVA, commented: "The RivieraWaves Bluetooth 5.4 IP provides our customers with a SIG qualified platform on which to build the lowest power Bluetooth 5.4 SoCs, including those wishing to target the rapidly expanding electronic shelf label market... Yet again, we are the first IP provider to achieve Bluetooth SIG qualification for the latest standard including all optional features, ensuring our customers can get to market quickly, with less risk and lowest cost."

07:07 EDT Zapata AI to become public through Andretti Acquisition combination - Zapata Computing and Andretti Acquisition (WNNR) announced that they have entered into a definitive business combination agreement that will result in Zapata AI becoming a U.S. publicly listed company. Upon closing of the transaction, the combined company is expected to be listed on the New York Stock Exchange under the new ticker symbol (ZPTA). Zapata AI spun out of Harvard University in 2017 with a mission to create value for enterprises with generative AI and other advanced algorithms that leverage quantum techniques. The transaction values Zapata at an implied pre-money equity value of $200M, with existing Zapata shareholders set to roll over 100% of their equity into the combined entity, or 20M shares at a price of $10.00. Andretti Acquisition Corp.'s sponsors and certain investors that own or have the right to receive founder shares will own a combined 5.8M shares, or an implied value of approximately $58M. Andretti Acquisition Corp.'s public shareholders currently hold approximately 7.9M shares, all of which are subject to redemption. The pro forma equity value of the combined company is expected to be between $281M and $365M, depending on the level of redemptions. The boards of directors of each of Zapata and Andretti Acquisition Corp. have approved the transaction. The transaction will require the approval of the stockholders of Andretti Acquisition Corp. and is subject to satisfaction or waiver of the conditions stated in the business combination agreement and other customary closing conditions, including the receipt of certain regulatory approvals. The transaction is expected to close in the first quarter of 2024.

07:06 EDT Applied Therapeutics completes pre-NDA for govorestat - Applied Therapeutics announced successful completion of a recent pre-New Drug Application, or NDA, meeting with the FDA regarding its govorestat, or AT-007, Galactosemia program. Based on discussions with the FDA, the Company believes they are aligned with the FDA and plans to submit an NDA for govorestat for the treatment of Galactosemia in the fourth quarter of this year.

07:04 EDT Ivanhoe Electric reports results from IA for its Santa Cruz Copper Project - Ivanhoe Electric provided the results from the Initial Assessment, or IA, for its Santa Cruz Copper Project, located west of Casa Grande, Arizona. The IA is a preliminary technical and economic study for the Santa Cruz Copper Project and associated high-grade mineral resources included in the Santa Cruz and East Ridge deposits. The study analyzes the potential for a high-grade underground copper mining operation supported by modern technologies to reduce environmental impact and powered predominantly by renewable energy. Highlights of the Initial Assessment include: Santa Cruz IA outlines a potential 5.9M tonnes per year underground mining operation, supported by 105.2M tonnes of modeled mill feed with an average grade of 1.58% copper from the Santa Cruz and East Ridge Deposits, resulting in an estimated 20-year mine life. The IA focuses exclusively on the high-grade exotic, oxide and enriched domains of the Santa Cruz and East Ridge Deposits. The oxide and enriched domains of the Texaco Deposit are not included in the current study. Future studies could evaluate the potential addition of the large primary sulfide domains at Santa Cruz and at the Texaco Deposit subject to market conditions. Copper recoveries of 95.4% are expected to be achieved through a combination of solvent extraction and electrowinning and conventional froth flotation. The IA includes LOM production for the Project of 1.0M tonnes of copper in the form of 99.99% pure copper cathode and 600,000 tonnes of copper contained in a 48% copper concentrate with very low deleterious elements, such as arsenic or lead. LOM average C1 cash costs are expected to be $1.36 per payable pound of copper, with C3 total costs expected to average $2.84 per payable pound of copper. The IA contemplates initial project capital expenditures of $1.15B, and LOM sustaining capital expenditures totaling $980M. A three-year construction period is envisioned to develop the underground workings and build the surface processing facilities. The IA estimates that the Project has a pre-tax net present value of $1.6B at an 8% discount rate and a pre-tax internal rate of return of 25.1%, using a flat LOM copper price assumption of $3.80 per pound. After-tax NPV is estimated at $1.3B with an after-tax IRR of 23.0%, using the same discount rate and copper price assumptions.

07:02 EDT Enthusiast Gaming, Netflix, Metavision collaborate to bring manga to Fornite - Enthusiast Gaming and Metavision have collaborated with Netflix (NFLX) to launch its Fortnite Creative experience for the manga series in history: ONE PIECE, in celebration of the new live-action version streaming globally on Netflix beginning August 31. "This collaboration with Netflix is an exciting example of how Enthusiast Gaming is creating unique and immersive experiences for brands that are scalable across digital entertainment and gaming platforms," said Amanda Rubin, EVP, Brand Solutions at Enthusiast Gaming. "NFL Tuesday Night Gaming continues to offer a distinct opportunity to engage diverse communities through shared passions of gaming, sports, and entertainment."

07:01 EDT Aecom selected as lead designer for WSDOT project - AECOMwill serve as Lead Designer for the Washington State Department of Transportation's I-405/Brickyard to SR 527 Improvement Project, which will be led by Skanska. As part of an integrated design-build team, AECOM will work in partnership with the contractor, Skanska, to deliver this vital project.

06:57 EDT Stellus Capital provides unitranche financing in support of BV investment - Stellus Capital Management affiliates acted as administrative agent and provided senior debt financing and an equity co-investment in support of BV Investment Partners' growth-oriented investment in The Hardenbergh Group, a leading provider of non-clinical professional staffing, consulting, physician peer review and outsourced solutions to healthcare organizations nationwide.

06:54 EDT Arizona Sonoran Copper provides update on company activities - Arizona Sonoran Copper Company updates on exploration and development activities at the Cactus Mine Project, inclusive of the Parks/Salyer deposit. All activities are focused on de-risking its high-quality asset in a tier one location, in preparation for the pending step-up Pre-Feasibility Study expected in Q1 2024. Furthermore, the owner-operator team continues to strengthen with the appointment of Mr. Steve Dixon, M.Sc.; Chief Metallurgist. He will be managing the metallurgical programs in preparation for the base case PFS and Definitive Feasibility Study. Highlights include: On track and on budget to deliver a PFS in Q1 2024; Targeting step up from the Preliminary Economic Assessment's 28ktpa to 45-50ktpa and to a mine life well-beyond the 18 years previously outlined; PFS scope includes the enriched and oxide material, or approximately 75% of the total mineral resources; Building owner-operator team; Bernie Loyer, SVP Projects and Christopher White, Chief Mine Geologist; Steve Dixon, Chief Metallurgist; Anticipating high conversion of the 2.9B lb @ 1.015% TCu Parks/Salyer mineral resource estimate into the indicated category from the inferred category; Infill to indicated category drilling complete; Infill to measured category drilling is ongoing for a DFS expected in H2 2024; 2 years of positive metallurgical results now in hand for oxides and enriched material; Parks/Salyer enriched material shows comparable recovery rates to Cactus with potentially shorter leach periods; 90% recovery rates for oxides in the Cactus deposits and the Stockpile Project; DFS level metallurgical studies ongoing; Completed all major Cactus permits based on the 2021 PEA; Amendments will be made to accommodate the larger operation, post-PFS; Increased land to 5,368 acres by optioning the MainSpring Property, extending south from Parks/Salyer; Improves planning flexibility for the pending PFS; Creates additional exploration target; Nuton testwork continues to deliver positive results, providing optionality to scale the asset beyond the oxide and enriched base case; 61-82% estimated extraction rates of the primary sulphide material after 75-150 days of leaching

06:51 EDT RH announces proposal to restore One Ocean Drive - RH announced its intention to restore One Ocean Drive, Miami Beach, submitting an RFP and formally entering the bidding process for a long-term lease of this iconic public property. RH Chairman & CEO Gary Friedman outlined the Company's vision for this historic property in a letter promoting "A dramatic reimagination and restoration of the site to its historic origins as a public park, with two beautifully landscaped beach promenades providing direct public beach access and opening up significant view corridors from Ocean Drive." And added, "We expect to make a total capital investment in the range of $150M-$170M, inclusive of an estimated $50M in public benefits. The Company is seeking a 30-year lease term with a starting base rent of $7M, increasing a minimum of 3% annually, resulting in an average base rent of $11M, or $333M over the term of the lease. The estimated $50M in capital investments toward public benefits reflects RH's commitment to both the local community and to Miami Beach visitors from around the world. Additional public benefits include our offer of a $5M upfront payment to the City to cover lost rent and taxes during the two-year construction period, plus a $1M cultural contribution to the community, to be directed by the City. Additionally, the City of Miami Beach can expect an incremental $3.3M per year on average, or a total of approximately $100M in ad valorem, hotel occupancy, plus food and beverage taxes over the term of the lease. Total public benefits from lease payments and taxes are estimated to be $465M over the life of the lease. Of which, $430M directly benefiting the City of Miami Beach and $35M going towards other governmental jurisdictions that impact the lives of City of Miami Beach residents including, Miami-Dade County and the Miami-Dade County Public School District."

06:50 EDT Azimut Exploration, SOQUEM uncover spodumene-bearing pegmatite boulder field - Azimut Exploration reports that a spodumene-bearing pegmatite boulder field containing at least 12 mineralized boulders has been identified on the Galinee Property in the Eeyou Istchee James Bay region of Quebec. These encouraging preliminary field results obtained by Azimut and its partner SOQUEM confirm the strong prospectivity of the Property and support the upcoming maiden drilling program targeting the area immediately south of the Adina lithium discovery. The minimum 1,600-metre core drilling program will be initiated shortly. In addition to Galinee, substantial concurrent exploration programs are already underway or will soon commence following a lengthy period of access restrictions related to widespread forest fires. This includes work on projects for gold and copper-gold and lithium. HIGHLIGHTS: The boulder field in the northern part of the Property is characterized by the following features: At least 12 spodumene-bearing pegmatite boulders in a 650- by 350-metre area, not fully delineated at this stage. The area has extensive glacial sediment cover and only one outcrop. The dominant glacial direction is NE to SW. Most boulders are angular to sub-angular, generally indicative of short transport distances from the bedrock source. It is possible that some of the spodumene-bearing boulders originated from the non-outcropping target area where the bedrock will be drill-tested by the upcoming drilling program. Boulder sizes range from 0.5 x 0.5 metre to 1.5 x 1.5 metre, with spodumene constituting 5% to 20% of the pegmatite. Spodumene crystals range from a few centimetres to 20-25 centimetres long, with whitish and grey to pink colours. A portable LIBS analyzer was used to confirm the presence of lithium. Other associated minerals are quartz, potassium feldspar, white mica, apatite and tourmaline.These preliminary findings underscore the strong discovery potential for spodumene-bearing pegmatites on Galinee in the immediate vicinity of mineralized bodies on the adjacent Adina project belonging to Winsome Resources. Drilling on Adina has traced two east-west subparallel spodumene-bearing pegmatite zones, including the Main Zone over a strike length of 1,000 metres. Public data suggests both zones have shallow dips toward Galinee. At Galinee, the aim of the drilling program is two-fold: 1) intersect the down-dip extensions of Winsome's zones, and 2) investigate the strong potential for additional subparallel spodumene-bearing pegmatites starting at shallow depth on Galinee, immediately south of but geometrically above Adina's Main Zone. On a larger scale, the Galinee Property displays well-defined targets, including a 20-kilometre-long lithium-cesium-gallium-tin anomaly in lake sediments in the northwestern part of the Property. Outcrops in this area are rare, but its strong geochemical footprint underscores significant exploration potential roughly coincident with a NE-SW-trending sheared greenstone belt. To date, 107 grab rock samples have been collected from target areas on the Property and assay results are pending.

06:46 EDT Meridian Mining UK Societas appoints Gilbert Clark as CEO - Meridian Mining UK S announced the leadership updates including Gilbert Clark agreeing to take on the CEO role, and Susanne Sesselmann has accepted the Interim Chair role. As such, the Company has made the following Executive and Board changes: Gilbert Clark, a non-independent director of the Company, has been appointed as the Company's new CEO; Adrian McArthur, a non-independent director of the Company, has been re-appointed as President to continue the leadership of the Company's day-to-day operations and implementation of the Company's business; Martin McFarlane, is now Senior Vice President Strategy and Projects ; and Susanne Sesselmann, an independent director of the Company, has agreed to act as Interim Independent Chair of the Board following unanimous Board support.

06:39 EDT Terran Orbital announces new lineup of seven standard satellite bus platforms - Terran Orbital announced a new lineup of seven standard satellite bus platforms. These standards are built upon Terran Orbital's manufacturing capabilities, featuring components and modules that can be readily swapped out to accommodate different bus sizes and configurations. The seven bus platforms span the nano, micro, mini, and small classes. This new lineup of satellite configurations is derived from Terran Orbital's long history of nano satellites innovation and its micro satellite bus designed and built for the U.S. Space Development Agency's recently launched Tranche 0 Transport Layer mission and the coming Tranche 1 mission.

06:36 EDT Centrus Energy expects to begin HALEU production in October - Centrus Energy announced that it expects to begin production of High-Assay Low-Enriched Uranium, or HALEU, in October, approximately two months ahead of schedule, at the American Centrifuge Plant in Piketon, Ohio. Under a competitively-awarded, cost-share contract signed with the U.S. Department of Energy in 2022, Centrus is required to begin production of HALEU by the end of this year. In June, Centrus announced it had successfully completed its operational readiness reviews with the U.S. Nuclear Regulatory Commission, or NRC, and received NRC approval to possess uranium at the Piketon, Ohio site - the last major regulatory hurdle prior to beginning production. Centrus is now conducting final system tests and other preparations so that production can begin in October.

06:35 EDT Cummins, Daimler Truck and Paccar partner to localize battery cell production - Accelera by Cummins, the zero-emissions business unit of Cummins (CMI), Daimler Trucks & Buses, a Daimler Truck (DTRUY) company and Paccar (PCAR) are partnering to accelerate and localize battery cell production and the battery supply chain in the United States. The planned joint venture will manufacture battery cells for electric commercial vehicles and industrial applications, creating highly desirable U.S. manufacturing jobs in the growing clean technology sector. Total investment is expected to be in the range of $2B-$3B for the 21-gigawatt hour, or GWh, factory. Accelera by Cummins, Daimler Truck and Paccar will each own 30% of, and jointly control, the joint venture, which will initially focus on the lithium-iron-phosphate, or LFP, battery technology family for commercial battery-electric trucks. The LFP battery cells produced by the joint venture will be able to offer several advantages compared to other battery chemistries, including lower cost, longer life, and enhanced safety, without the need for nickel and cobalt raw materials. Accelera by Cummins, Daimler Truck and Paccar expect to see growing demand for battery technology throughout this decade and U.S. customers will benefit from a dedicated battery cell factory. EVE Energy will serve as the technology partner in the joint venture with 10% ownership and will contribute its battery cell design and manufacturing know-how. EVE Energy is a global leader in the manufacture of LFP battery cells for the vehicle industry and is publicly traded on the Shenzhen stock exchange. The transaction is subject to customary closing conditions, and receipt of applicable merger control / regulatory approvals including the submission of a voluntary notice to the Committee on Foreign Investment in the United States.

06:33 EDT Schneider National appoints Darrell Campbell as CFO - Schneider National (SNDR) announced Darrell Campbell will join the company on September 30, as Executive Vice President and CFO. He will be responsible for the company's financial strategies, planning and reporting - as well as all finance operations and investor relations. Campbell will succeed Steve Bruffett, who announced his retirement earlier this year. Bruffett will remain with the company until the end of the year to ensure a smooth transition. Before working at JM Family Enterprises, Campbell served as CFO of Carnival Cruise Line of the Carnival Corporation & PLC (CCL) leading all finance functions, as well as sourcing, supply chain and risk management. Campbell also served as Corporate Treasurer of Carnival Corporation, managing global treasury and tax functions. Prior to Carnival, Campbell gained experience working with publicly traded Fortune 500 companies while working as a partner for PricewaterhouseCoopers where he led financial statement and internal control audits across multiple industries.

06:26 EDT Liberty Gold submits pre-plan of operations for Black Pine Oxide Gold Project - Liberty Gold announced a significant milestone in the development of its Black Pine Project, located in Cassia and Oneida counties, Idaho. Pilot Gold, a wholly owned subsidiary of Liberty Gold Corp., has prepared and submitted the mining Pre-Plan of Operations for the Black Pine Oxide Gold Project, a critical step in the advancement of the project into the Federal and State permitting process and onwards, towards production. The Black Pine deposit is situated approximately 5 miles south of Juniper, Idaho, within the United States Forest Service Sawtooth National Forest and on adjacent lands administered by the U.S. Bureau of Land Management from the Pocatello Field Office. The project encompasses a largely contiguous block of 622 unpatented federal lode claims, state minerals, and private properties hosting a multi-million ounce oxide gold mineral resource. Liberty Gold has been exploring the project since acquisition in 2016 and recently completed the major milestone of one thousand exploration holes drilled by the Company on the property. The submission of the mining Pre-Plan of Operations for the Black Pine Project to the USFS, BLM and Idaho Governor's Office of Energy and Mineral Resources, is a further critical step in advancing the project. The conceptual project entails re-starting conventional open pit mining in pre-existing historical pits, expanding these pits, and developing new open pits in previously unmined areas. The extracted oxide gold mineralization would be processed using the well-established run-of-mine heap leaching method, with gold produced as dore bars on site. The Company is committed to maintaining the highest environmental standards and employing established metallurgical processes that have been used successfully at the Black Pine site and at many other mine sites. Liberty Gold is pleased to announce the selection of M3 Engineering as the Lead Engineer for the Black Pine Oxide Gold Project. The Company will continue to prioritize environmental studies, community engagement, and sustainable resource management as it progresses toward the formal submission of the Mine Plan of Operations expected in second half of 2024.

06:20 EDT Hammerhead Energy increases annual average production guidance to 41,500 boe/d - Based upon continued strong execution in the field with respect to both costs and performance, Hammerhead Energy announced increased 2023 annual average production guidance of 41,500 boe/d from the previous estimate of 40,200 boe/d. Crude oil production is estimated to be 35% of production from a prior estimate of 33%. Since coming on production August 6th, performance to date on the 12-well North Karr 10-14 pad has thus far materially exceeded the Company's internal forecast, with peak pad production exceeding 17,800 boe/d. As a result, field estimates of Hammerhead's corporate production volumes for the month of August averaged 48,500 boe/d, while also having additional production "behind pipe" due to North Karr total production capability exceeding infrastructure capacity. Based on the current commodity price strip, the 12-well pad at North Karr 10-14 is currently on track to achieve payout in three months or less based on average DCET well costs of only $7.9M per well. On the whole, corporate well performance has exceeded type curves at the same time that capital costs have come in lower than forecast. Due to these savings, Hammerhead is reducing its capital expenditures guidance in 2023 to $500M from $525M. Updated 2023 production guidance continues to assume that the new South Karr 5-11 nine-well pad does not commence production until January 2024, although drilling operations have been completed ahead of planned timing while expansion of infrastructure at South Karr is still expected to be completed before the end of 2024. Total 2023 cash costs per boe are also tracking previous guidance. Finally, we now note that based on the current commodity price strip, Hammerhead expects to enter into a "free funds flow" status earlier than previously anticipated, in October 2023. As previously communicated, Hammerhead expects to introduce a formal return of capital strategy beginning in 2024, subject to approval by Hammerhead's Board of Directors. Scott Sobie, President and CEO of Hammerhead notes, "Our business is improving dramatically with accelerated momentum due to capital efficiencies and production results being better than expected. Our transition to meaningful free cash flow in 2024, as well as a return of capital strategy, is an exciting pivot for our firm. The implications of our South Karr asset coming on line could verify our expectations of increased production results that have the potential to be the strongest among our whole asset base, and in addition, will provide several new Lower Montney tests."

06:14 EDT Roku reports workforce reduction, measures to bring down y/y operating expenses - Roku said in a regulatory filing that in light of its continuing evaluation of its operations, on September 5, 2023, the company determined to implement additional measures to continue to bring down its year-over-year operating expense growth rate by consolidating its office space utilization, performing a strategic review of its content portfolio, reducing outside services expenses, and slowing its year-over-year headcount expense growth rate through a workforce reduction and limiting new hires, among other measures. The workforce reduction is expected to impact approximately 10% of the company's employees. The company expects to record a restructuring charge related to the workforce reduction, primarily consisting of severance and benefits costs, in a preliminary estimated range of $45M-$65M. The company expects that the majority of the restructuring charge will be incurred in the third quarter of fiscal 2023. The company further anticipates that the implementation of the workforce reduction, including cash payments, will be substantially complete by the end of the fourth quarter of fiscal 2023.

06:13 EDT Roku: Workforce reduction to impact 10% of company's employees

06:11 EDT CareTrust REIT completes joint venture to acquire La Fuente Post Acute - CareTrust REIT announced that it has completed a joint venture investment to acquire La Fuente Post Acute, a 187-bed skilled nursing facility located in Vista, California. Once regulatory approval is obtained, the facility will be operated by Bayshire Senior Communities, a tenant of CareTrust, pursuant to a new 15-year lease with the joint venture landlord. To acquire the facility, CareTrust and a third-party regional healthcare real estate investor entered into a joint venture. CareTrust's combined common equity and preferred equity investments in the joint venture total $25.5M. CareTrust's initial contractual yield on its combined preferred and common equity investments in the joint venture is approximately 9.7%. The lease provides for 3% fixed annual rent escalators and two, 5-year extension options. CareTrust is the managing member of the joint venture entity. The investments were funded using cash on hand.

06:10 EDT Alaska Air now sees Q3 revenue up 1%-2% vs. prior view of flat to up 3% - In an investor update, Alaska Air said: "Over the past several weeks, fuel prices have increased considerably, driving a downward revision to our adjusted pre-tax margin expectations for the quarter. We now expect economic fuel cost per gallon to be approximately $3.15 to $3.25 and adjusted pre-tax margin to be 10% to 12% for Q3 2023. Our operation continues to perform at an exceptionally high level and throughout peak summer flying our completion rate reached record levels during July and August. We also executed a market wage rate adjustment for our pilots, effective September 1, 2023 as part of the agreement originally reached in October 2022. Inclusive of this impact, we are revising our CASMex guide to the better end of our range, which we now expect to be down 1% to 2% for Q3 2023. Regarding revenue, close-in booking strength continued through August, however, the tragic fires that occurred on Maui have resulted in cancellations to the island as the community works to recover. Given these offsetting impacts, we are tightening our revenue guide to up 1% to 2%, with the midpoint unchanged from our original guidance."

06:07 EDT Gevo executes $30M award with USDA - Gevo announced it has finalized and executed a Notice of Grant and Agreement Award with the U.S. Department of Agriculture, or USDA, for a Partnerships for Climate-Smart Commodities grant of up to $30M for Gevo's Climate-Smart Farm-to-Flight Program. This program is aimed at tracking and quantifying the carbon-intensity, CI, impact of climate-smart practices while creating market incentives for low CI corn to help accelerate production of sustainable aviation fuel, or SAF, and low-CI ethanol. The company believes this grant will play a pivotal role in expediting the adoption of climate-smart farming practices and immediate market expansion of field-tracked, low-CI corn destined for SAF production in the area surrounding Gevo's previously announced Net-Zero 1 SAF plant, currently under development in Lake Preston, South Dakota.

06:05 EDT Kraft Heinz announces launch of FUNdamental Textbooks - Kraft Heinz's kids' brands are getting into the book business with the launch of the new FUNdamental Textbooks. Each book delivers a 'lesson' on Jiggleometry, Nibbleomics, Slurpstory and Stackonomy, while providing a dsurprise snack via hollowed out pages featuring brands kids know and love. The book series was created to infuse excitement, engagement, and playfulness into learning. Starting today, the books will be available for parents at www.fundamentaltextbooks.com with no purchase necessary, while supplies last. For every book claimed, Kraft Heinz will donate $10 to First Book, a non-profit organization that works to remove barriers to education and level the playing field for kids in need so that every child has access to a quality education. In addition, Kraft Heinz is making a one-time donation of $50,000 to First Book.

06:03 EDT System1 confirms receipt of indication of interest for Total Security - System1 is in receipt of a non-binding indication of interest from Just Develop It regarding the possible acquisition of Total Security. The offer consists of $240 million in cash, the assumption of certain potential earnout payments in respect of Total Security and the delivery of approximately 29 million System1 shares held by Just Develop It and related persons. A special committee of the System1 board of directors has been formed that will evaluate among other things, this non-binding indication of interest. The special committee, together with its advisors, Solomon Partners and Weil, Gotshal & Manges LLP, are evaluating the offer and considering alternatives. There can be no assurance that the transaction described in the non-binding indication of interest, or any other transaction, will be completed or, if so, as to the timing, price and other terms and conditions of any such transaction. The Company does not intend to disclose developments with respect to this matter until such time as the board of directors approves a transaction or otherwise deems further disclosure appropriate, except as required by law or other regulatory requirements.

05:21 EDT Tellurian, Baker Hughes enter supply agreement - Tellurian (TELL) and Baker Hughes (BKR) announced an agreement to supply eight main refrigerant compression packages for Phase 1 of the Driftwood LNG project. The agreement secures a delivery schedule for the eight LM6000PF+ gas turbines, main refrigerant compressors, and control units required for Phase 1, supporting Driftwood's ability to achieve initial liquefied natural gas, or LNG, production in 2027. Baker Hughes is also on schedule to complete, by early next year, fabrication of the electric-powered, zero-emissions Integrated Compressor Line packages and other turbomachinery equipment for Driftwood Pipeline 200, following the award in 2022.

05:16 EDT UMC reports August revenue NT$18.95M, down 25.23%

05:08 EDT Paysafe, Eightcap announce strengthening of partnership - Paysafe and Eightcap are excited to announce the strengthening of their partnership through the introduction of an Embedded Trading Wallet solution. This strategic collaboration aims to provide a joint embedded finance solution for Eightcap and Paysafe's shared partners and merchants.